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1.	  INTRODUCTION	  	  	  	  1.1	   SURGERY	  IN	  MUSCULO-­‐SKELETAL	  ONCOLOGY	  	  	   Thanks	   to	   the	   recent	   and	   constant	   improvements	   in	   imaging	  techniques,	   chemotherapy	   protocols,	   radiotherapy	   and	   surgery,	   the	  possibility	   to	   perform	   wide	   tumor	   resection	   and	   subsequent	  functional	  reconstruction	  has	  become	  more	  and	  more	  achievable,	  and	  now	   it	   represents	   the	   starting	   point	   for	   the	   great	   part	   of	   treatment	  approach	   in	   muscolo-­‐skeletal	   tumor	   surgery.	   Compared	   to	   30-­‐40	  years	   ago,	   ablative	   surgery	   (amputation)	   is	   reserved	   to	   very	   rare	  cases,	  in	  which	  the	  size	  of	  the	  lesion	  or	  the	  neuro-­‐vascular	  structures	  involvement	   influence	   the	   treatment	   choice	   leading	   to	   an	   absolute	  impossibility	  to	  achieve	  reconstructive	  options	  (1-­‐5).	  For	  the	  majority	  of	   the	   cases,	   instead,	   the	   surgical	   gold	   standard	   is	   a	   wide	   resection	  followed	   by	   reconstruction.	   Reconstruction	   techniques	   are	   evolving	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from	  purely	  anatomical	  to	  functional	  for	  both	  bone	  and	  soft	  tissues,	  in	  some	  cases	  with	  the	  inclusion	  of	  vessels	  and	  nerves.	  In	   sarcoma	   surgery	   the	   concept	   of	   “margin”	   is	   of	   paramount	  importance	   for	  an	  adequate	   treatment.	   In	  general,	   the	  base	  principle	  in	   the	   resection	   of	   malignant	   tumors	   of	   bone	   and	   soft	   tissues	   is	   to	  obtain	  “wide”	  margins,	  which	  means	  excision	  of	  the	  tumor	  surrounded	  by	  a	  reasonable	  amount	  (usually	  at	   least	  2	  cm	  all	  around)	  of	  healthy	  tissue	   with	   no	   evidence	   of	   tumor	   (6-­‐9).	   In	   fact,	   any	   other	   type	   of	  resection,	   such	   as	   “marginal”	   or	   “intra-­‐lesional”,	   is	   considerate	  inadequate	  for	  sarcoma	  surgery,	  as	  the	  most	  likely	  outcome	  would	  be	  a	  recurrence	  of	  the	  lesion	  and	  possible	  metastatic	  spread	  (10-­‐13).	  The	  gold	   standard,	   therefore,	   is	   the	  wide	   excision.	   This	   type	   of	   resection	  was	   considered	   inadequate	   in	   the	   early	   ages	   of	   sarcoma	   surgery	  definitions,	   while	   the	   “radical”	   excision	   was	   considered	   the	   best	  possible	   treatment.	   The	   radical	   margin,	   or	   compartimental,	   is	   a	  resection	  of	  the	  lesion	  together	  with	  the	  entire	  compartment	  in	  which	  the	   lesion	   is	   located.	   It	   is	   clear	   therefore,	   that	   in	   this	   case	   the	  aggressiveness	   of	   the	   surgery	   is	   massive	   and	   that	   many	   times	   this	  surgery	  was	  synonymous	  of	  amputation	  (Fig.1).	  It	  has	  been	  demonstrated	  over	  the	  years	  that,	  in	  terms	  of	  overall	  survival	  and	  disease	  free	  survival,	  the	  outcome	  of	  a	  wide	  excision	  are	  comparable	  with	  the	  outcome	  of	  a	  radical	  excision,	  therefore	  sarcoma	  surgery	   has	   moved	   towards	   the	   concept	   of	   “limb	   sparing	   surgery”	  with	  a	  decrease	  of	  morbidity	  at	  the	  level	  of	  the	  resection	  (14).	  Despite	  these	  advances	   in	   treatment,	  usually	   the	  resection	  at	   the	   level	  of	   the	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bone	  or	   the	   soft	   tissue	   is	   still	   quite	   extensive,	   and	   generally	   there	   is	  the	   necessity	   for	   reconstruction	   in	   order	   to	   guarantee	   the	   best	  possible	   outcome	   to	   the	   patient.	   It	   is	   therefore	   extremely	   important	  having	   reconstruction	   techniques	   which	   allow	   not	   only	   a	   good	  anatomic	  and	  aesthetic	  coverage	  of	  the	  defect,	  but	  even	  an	  acceptable	  functional	  recovery,	  especially	  now	  that	  the	  long	  term	  survivorship	  is	  definitely	  longer	  than	  in	  the	  past.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Fig.	  1.	  Enneking	  classification	  of	  margins	  in	  soft	  tissue	  sarcomas.	  
	   9	  
-­‐ Bone	  sarcomas	  
Many	   type	   of	   bone	   sarcomas	   are	   known,	   and	   the	   majority	  involves	  young	  adults.	  Osteosarcomas	  (OS)	  and	  Ewing	  sarcomas	  (ES),	  in	   fact,	   are,	   among	   the	   others,	   the	   most	   common	   primary	   bone	  sarcomas,	   and	   the	   majority	   of	   the	   patients	   affected	   are	   in	   their	   2nd	  decade	   of	   life.	   On	   the	   other	   hand,	   Chondrosarcomas	   (CS),	   are	   more	  commonly	  diagnosed	  in	  adult	  patients,	  in	  general	  older	  than	  40	  years	  of	   age.	   In	   terms	   of	   treatment	   strategies,	   while	   OS	   and	   ES	   usually	  respond	  relatively	  well	  to	  chemotherapy	  (and	  radiotherapy	  in	  the	  case	  of	   ES),	   CS	   are	   not	   responsive	   to	   adjuvant	   therapies	   and	   surgery	  constitutes	   the	  main	   treatment	  option.	   In	  any	  case,	   regardless	  of	   the	  help	   of	   chemotherapy	   or	   radiotherapy,	   surgery	   remains	   one	   of	   the	  corner	   stones	   of	   treatment,	   which	   implies	   removal	   of	   the	   diseased	  bone	  and,	  therefore,	  subsequent	  necessity	  for	  reconstruction.	  When	   a	   sarcoma	   involves	   the	   bone,	   the	   main	   choices	   for	   the	  surgeon	  are:	  1)	  mega-­‐prosthesis,	  which	  can	  replace	  the	  lost	  bone	  with	  adjacent	  joint,	  and	  2)	  bone	  or	  osteoarticular	  allograft,	  which	  are	  used	  when	   a	   biologic	   reconstruction	   is	   preferred	   to	   a	   prosthetic	   one.	   The	  advantages	   of	   the	   biologic	   reconstruction	   compared	   to	   a	   prosthetic	  one	   are	   to	   be	   seen	   in	   the	   view	  of	   an	   improved	   and	   longer	   outcome,	  especially	   in	   the	   young	   patient,	   together	   with	   the	   possibility	   to	   re-­‐attach	   structures	   such	   as	   tendons	   and	   ligaments	   which	   otherwise	  would	  be	   lost.	  Therefore	  some	  authors	  believe	   that	   this	   technique,	   if	  properly	  performed	  and	  in	  the	  absence	  of	  complications,	  could	  allow	  a	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superior	   quality	   of	   the	   reconstruction	   compared	   to	   the	   prosthetic	  technique	  (15,	  16).	  It	   is	   well	   known,	   however,	   that	   the	   risks	   associated	   with	   a	  biologic	   reconstruction	   are	   generally	   superior	   compared	   to	   a	  prosthetic	   one,	   and	   in	   fact	   many	   complications	   can	   occur	   and	   are	  understandably	   discouraging,	   especially	   because	   they	   increase	   with	  the	   increase	   of	   the	   follow-­‐up	   (16-­‐18).	   It	   is	   therefore	   absolutely	  necessary	  an	  improvement	  of	  this	  technique,	  especially	  in	  the	  possible	  strategies	   that	   allow	   a	   re-­‐vitalization	   of	   the	   allograft.	   In	   this	   optic,	  tissue	  engineering	  could	  represent	  the	  ideal	  solution,	  and	  researchers	  around	  the	  world	  are	  working	  to	  define	  the	  best	  possible	  strategy	  to	  obtain	  the	  perfect	  and	  most	  durable	  biologic	  reconstruction.	  	  
-­‐ Soft	  tissues	  sarcomas	  
Soft	   tissue	  sarcomas	  (STS)	  are	  malignant	   lesions	  arising	   in	   the	  muscle	  or	  subcutaneous	  tissue	  of	  the	  body,	  or	  more	  rarely	  in	  a	  nerve	  or	  in	  the	  joint	  space.	  As	  it	  happens	  for	  bone	  sarcomas,	  there	  is	  a	  wide	  variety	  of	  different	  pathologic	  types	  of	  sarcomas,	  which	  are	  defined	  on	  the	   base	   of	   the	   type	   of	   cells	   that	   they	   express	   the	   most	   from	   the	  histologic	   point	   of	   view;	   the	   most	   common	   STS	   are	   liposarcoma,	  Malignant	   Fibrous	   Histocytoma	   (MFH),	   Leyomiosarcoma,	  Pleyomorphic	   sarcoma,	   Schwannoma.	   All	   these	   lesions	   are	   more	  commonly	  diagnosed	  in	  adult	  patients,	  in	  general	  after	  the	  4th	  decade	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of	   life,	   and	   the	   vast	   majority	   of	   them	   responds	   relatively	   well	   to	  adjuvant	  radiotherapy.	  From	  the	  surgical	  point	  of	  view,	  depending	  on	  where	   the	   lesion	   is,	   what	   is	   its	   size	   and	   which	   compartment	   of	   the	  body	   is	   involved,	   the	   excision	   could	   be	   quite	   extensive	   and	   could	  involve	   large	  part	  of	   the	  skin	  and/or	   the	  subcutaneous	   tissue.	   In	   the	  majority	   of	   the	   cases	   the	   surgery	   is	   “conservative”	   enough	   to	  guarantee	   a	   good	   primary	   closure	   of	   the	   wound.	   In	   some	   cases,	  however,	   there	   is	   the	   necessity	   of	   cutaneous	   or	   musculo-­‐cutaneous	  flap	  in	  order	  to	  be	  able	  to	  close	  the	  wound,	  and	  this	  happens	  when	  the	  lesion	   oblige	   the	   surgeon	   to	   excise	   big	   part	   of	   the	   superficial	   tissue	  with	  the	  impossibility	  of	  a	  primary	  wound	  closure.	  	  
Thanks	  to	  plastic	  surgery	  techniques,	  it	  is	  possible	  now	  to	  excise	  extremely	  big	  soft	  tissue	  lesions	  without	  the	  necessity	  to	  amputate	  the	  limb,	   as	   long	   as	   the	  main	  neuro-­‐vascular	   bundle	   is	   not	   involved	   and	  can	  be	  safely	  dissected.	  
The	   use	   of	   plastic	   flaps,	   however,	   is	   able	   to	   guarantee	   only	   a	  coverage	   of	   the	   defect	   left	   after	   the	   tumor	   excision,	   without	   the	  possibility	   of	   regain	   the	   function	   of	   the	   lost	  muscle(s).	   The	   use	   and	  advantages	  of	  innovative	  plastic	  reconstruction	  techniques	  is	  the	  goal	  of	  the	  second	  part	  of	  this	  study.	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1.2	   SURGICAL	   RECONSTRUCTION	   AFTER	   BONE	   SARCOMA	  RESECTION	  	  After	   bone	   loss	   for	   sarcoma	   resection,	   there	   is	   the	   necessity	   to	  replace	   the	   defect.	   To	   do	   this,	   the	   surgeon	   can	   choose	   between	   a	  prosthetic	  reconstruction	  and	  a	  biologic	  reconstruction.	  	  
-­‐ PROSTHETIC	  BONE	  RECONSTRUCTIONS	  	  
After	   massive	   bone	   resections	   in	   limb	   sparing	   surgery,	   there	   is	  clearly	   the	   necessity	   for	   anatomic	   and	   functional	   reconstruction.	  When	  the	   lesion,	  and	  therefore	   the	  resection,	   involves	  an	  area	  of	   the	  bone	  particularly	  close	  to,	  or	  at	  the	  level	  of	  the	  joint,	  the	  gold	  standard	  reconstruction	   technique	   is	   the	   use	   of	   a	   mega-­‐prosthesis	   (19-­‐23).	  These	   type	   of	   special	   prosthesis	   are	   particularly	   useful	   in	   tumor	  surgery,	   because	   they	   not	   only	   replace	   the	   joint,	   as	   a	   normal	  orthopaedic	  prosthesis	  does	  in	  case	  of,	  for	  example,	  osteoarthritis,	  but	  they	  allow	  the	  replacement	  of	  the	  resected	  bone	  as	  well	  (21,	  24,	  25).	  Sometimes	   these	   prosthesis	   can	   reconstruct	   the	   entire	   length	   of	   the	  bone,	   as	   in	   the	   case	  of	   a	   total	   femur	   replacement,	   in	  which	  both	   the	  knee	  and	  the	  hip	  joint	  are	  replaced	  together	  with	  the	  entire	  femur	  (22,	  26-­‐28).	  Mega-­‐prosthesis	  are	   the	  best	  possible	  strategy	  when	  there	   is	  the	   necessity	   to	   sacrifice	   a	   joint,	   because	   they	   allow	   a	   hypothetical	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return	  to	  function	  when	  the	  muscles	  that	  govern	  the	  replaced	  joint	  are	  still	  in	  place	  and	  functional	  (29-­‐33).	  The	  main	  quality	  of	  mega-­‐prosthetis,	  together	  with	  their	  ability	  to	  replace	  the	  missing	  bone	  and	  joint,	  is	  that	  they	  guarantee	  a	  relatively	  long	   functional	   life	   and	   the	   possibility	   for	   the	   patient	   to	   start	  mobilizing	  in	  the	  immediate	  days	  after	  the	  surgery	  (29,	  31,	  32).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  Despite	   the	   numerous	   advantages	   in	   the	   use	   of	  mega-­‐prosthesis,	  there	   are	   many	   conditions	   that	   can	   impair	   their	   function	   (25)	   and	  
	   	  	  
Fig.	  2	  Example	  of	  bone	  sarcoma	  located	  to	  the	  proximal	  femur,	  
treated	  with	  proximal	  femur	  resection	  and	  reconstruction	  with	  
proximal	  femur	  mega-­‐prosthesis	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limit	   their	   success:	   1)	   The	   risk	   of	   infection	   is	   very	   high,	   and	   in	  particular	   is	  much	   higher	   compared	   to	   joint	   replacement	   prosthesis	  for	  arthritis	  (34).	  This	  is	  because	  the	  bone-­‐cartilage	  resection	  is	  much	  bigger,	  the	  length	  of	  the	  surgery	  is	  longer	  with	  longer	  exposure	  of	  the	  wound,	   usually	   patients	   are	   immune-­‐compromised	   due	   to	   neo-­‐adjuvant	   chemotherapy	   or	   radiotherapy	   and,	   finally,	   the	   soft	   tissue	  coverage	   of	   the	   prosthesis	   might	   be	   insufficient.	   In	   a	   recent	   study,	  infection	  has	  been	  proven	  to	  be	  the	  most	  common	  mode	  of	  failure	  for	  this	  type	  of	  prosthesis	  (35);	  	  2)	  The	  achievement	  of	  complete	  function	  is	   generally	   somehow	   limited	   due	   to	   the	   loss	   of	   muscle	   and	   the	  difficulty	  and	  sometimes	  impossibility	  to	  re-­‐attach	  musculo-­‐tendinous	  insertions	   into	   the	   prosthesis	   (25,	   36);	   3)	   In	   the	   young	   patient,	   the	  longevity	   of	   the	   prosthesis	   is	   usually	   insufficient,	   with	   the	   need	   of	  multiple	   revisions	   and	   loss	   of	   bone	   stock,	   which	   increases	   the	  morbidity	   of	   this	   treatment	   together	   with	   the	   risk	   of	   subsequent	  infection;	   4)	   Aseptic	   loosening	   has	   been	   considered	   one	   of	   the	  most	  common	   cause	   of	   failure	   in	   both	   cemented	   and	   non	   cemented	  implants,	   and	   is	   associated	   with	   reduction	   of	   the	   longevity	   of	   the	  reconstruction;	  at	  the	  same	  time,	  this	  complication	  limits	  the	  possible	  surgical	  options	  for	  revision	  because	  of	  the	  decrease	  of	  available	  bone	  stock	  (35).	  Taking	   into	   account	   all	   these	   aspects,	   it	   is	   clear	   how	   an	  improvement	   in	   the	   current	   techniques	   appears	   necessary,	   because	  there	   is	   the	   absolute	   need	   to	   improve	   the	   clinical	   and	   functional	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outcome	  of	  our	   reconstructions	  and,	   at	   the	   same	   time,	   the	  quality	  of	  life	  of	  these	  already	  proven	  patients.	  	  
-­‐ BIOLOGIC	  BONE	  RECONSTRUCTIONS	  	  
When	   the	   bone	   segment	   involved	   by	   the	   tumor	   is	   relatively	   far	  from	   the	   articular	   joint,	   a	   biologic	   reconstruction	   can	   be	   taken	   in	  consideration.	  The	  reason	  for	  the	  relative	  exclusion	  criteria	  in	  case	  the	  joint	   is	   involved	   refers	   to	   the	   early	   degeneration	   of	   the	   cartilage,	  which	   leads	   to	   early	   osteoarthritis	   and	   consequent	   necessity	   for	  relatively	   early	   new	   joint	   replacement	   intervention	   (18,	   37-­‐40).	   In	  some	   occasion,	   however,	   especially	   when	   the	   patient	   is	   very	   young	  (usually	   up	   to	   the	   adolescence),	   a	   biologic	   reconstruction	   can	   be	  attempted	   even	   to	   replace	   a	   joint,	   with	   the	   hope	   that	   re-­‐vascularization	   and	   synovial	   fluid	   re-­‐constitution	   would	   be	   able	   to	  give	  enough	  nutrients	  to	  the	  replaced	  cartilage	  to	  survive	  (41,	  42).	  	  The	   most	   common	   material	   used	   for	   biologic	   reconstruction	   is	  allogenic	  bone	   (or	  bone	  allograft).	  This	   type	  of	   tissue	   is	  provided	  by	  the	   so-­‐called	   “bone	   banks”,	   which	   are	   institutes	   that	   store	   bones	  harvested	  from	  organs	  donors.	  One	  of	  the	  most	  important	  qualities	  of	  bone	   and	   cartilage	   allografts	   compared	   to	   other	   tissues	   or	   organs	   is	  that	   there	   is	   no	   need	   for	   immune-­‐suppressive	   therapy	   for	   the	  recipient,	  because	  this	  tissue	  does	  not	  have	  enough	  surface	  antigens	  to	  provoke	  and	  immune	  reaction	  (43).	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The	  main	  advantages	  in	  the	  use	  of	  bone	  allografts	  are	  to	  be	  seen	  in	  the	   possibility	   to	   replace	   significant	   bone	   and	   sometimes	   osteo-­‐chondral	   defects	   maintaining	   all	   the	   main	   bone-­‐tendon	   and	   bone-­‐ligament	   attachments,	   therefore	   allowing	   a	   better	   and	   more	  anatomical	   function	   compared	   to	   a	   mega-­‐prosthesis	   (44,	   45).	   If	  satisfactory	  results	  are	  obtained,	  the	  reconstruction	  can	  last	  for	  many	  years	   with	   a	   great	   functional	   advance	   for	   the	   patient.	   (Fig.3).	  Potentially	   the	   implication	   of	   a	   biologic	   reconstruction,	   therefore,	   is	  extremely	   attractive,	   however	   there	   are	   still	   many	   reasons	   why	   the	  use	   of	   allograft	   is	   limited	   to	   selected	   cases	   and	  maintain	   the	   use	   of	  prosthesis	  as	  a	  gold	  standard	  in	  the	  majority	  of	  the	  cases.	  The	  main	  disadvantages	  in	  the	  use	  of	  a	  biologic	  reconstruction	  are:	  	  1. Risk	  of	  non-­‐union	  or	  pseudo-­‐arthrosis	  (46).	  The	  integration	  between	  the	  host	  bone	  and	  the	  allograft	   is	  one	  of	   the	  weak	  points	  of	   this	   technique.	  The	  allograft,	   in	   fact,	   is	  a	  structure	  that	   is	   constituted	   by	   dead	   bone/cartilage,	   therefore	   the	  integration	   process	   occurs	   only	   in	   one	   direction,	   from	   the	  host	  to	  the	  graft,	  and	  depends	  only	  on	  the	  quality	  of	  the	  host	  bone.	   The	   process	   ideally	   should,	   with	   time,	   replace	   the	  entire	  allograft	  with	  host	  bone,	  but	  in	  reality	  the	  integration	  between	  the	  2	  structures	  involves	  only	  few	  millimiters	  of	  the	  implant,	  while	   the	   rest	   of	   the	   allograft	   remains	   constituted	  by	  non-­‐vital	  bone	  (47-­‐49).	  As	  a	  consequence	  of	   this	   limited	  and	  slow	  integration	  process,	  the	  rest	  from	  any	  activity	  has	  to	   be	   prolonged	   for	   at	   least	   3	   months,	   and	   sometimes	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patients	   require	   up	   to	   12	   months	   before	   they	   can	   start	  weight	  bear	  on	  the	  operated	  limb	  (50,	  51).	  	  	  	  	  	  	  	  	  	  	  
	  	   2. Risk	  of	   infection	   (52).	  The	   causes	   are	   the	   same	  present	   for	  prosthesis,	  such	  as	  the	  long	  length	  of	  the	  surgery	  and	  the	  fact	  that	  the	  patient	  is	  usually	  immune-­‐compromised.	  To	  this	  the	  
	  
Fig.	   3	   Case	   of	   a	   6-­‐year-­‐old	   boy	   with	   a	   diagnosis	   of	   osteosarcoma	   in	   whom	   a	  
transepiphyseal	   resection	   and	   reconstruction	  with	   an	   intercalary	   allograft	  
was	   performed.	   (A)	   The	   anteroposterior	   radiograph	   of	   the	   knee	   after	  
neoadjuvant	   chemotherapy	   shows	   the	   osteosarcoma	   compromises	   the	  
medial	  cortex	  with	  a	  varus	  deformity.	  (B)	  A	  coronal	  T1-­‐weighted	  MRI	  image	  
shows	   the	  metaphyseal	  and	  diaphyseal	   extension.	   (C)	  A	  schematic	  drawing	  
shows	   the	   preoperative	   planning	   of	   the	   reconstruction.	   (D)	   The	  
anteroposterior	  radiograph	  shows	  the	  intercalary	  allograft	  after	  2	  years	  of	  
followup.	   (REF:	   Muscolo	   DL,	   Ayerza	   MA,	   Aponte-­‐Tinao	   L,	   et	   al.	   Allograft	  
reconstruction	   after	   sarcoma	   resection	   in	   children	   younger	   than	   10	   years	  
old.	  Clin	  Orthop	  Relat	  Res.	  2008;466:1856-­‐1862,	  with	  kind	  permission	  from	  
Springer	  Science+Business	  Media.)	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aspect	   of	   the	   allograft	   biology	   needs	   to	   be	   added.	   The	  allograft,	   in	   fact,	   being	   for	   the	   main	   part	   non-­‐vascularized	  and	  non-­‐vital,	  can	  represent	  an	  ideal	  environment	  for	  micro-­‐organisms.	  3. Risk	   of	   fracture	   (53).	   This	   risk	   is	   again	   due	   to	   the	  avascularity	   and	   non	   vitality	   of	   the	   bone,	   which	   cannot	  undergo	   to	   the	   usual	   mechanism	   of	   micro-­‐cracks	   and	  remodelling	   of	   normal	   bone.	   In	   this	   situation,	   in	   fact,	   the	  micro-­‐cracks	   will	   occur	   without	   repair	   and	   with	   time	   this	  will	  lead	  to	  a	  proper	  fracture.	  4. Risk	   of	   early	   osteoarthritis.	   In	   the	   case	   of	   osteo-­‐articular	  allografts,	   cartilage	   remains	   constituted	   by	   entrapped	   and	  not-­‐vital	   chondrocytes,	   which	   cannot	   receive	   any	   nutrient,	  nor	   from	  the	  synovial	   fluid	  nor	   from	  the	  subchondral	  bone.	  This	  will	  inevitably	  lead	  to	  degenerative	  changes	  and,	  in	  the	  long	  term,	  early	  onset	  of	  osteo-­‐arthritis	  (54,	  55).	  When	  all	   these	  possible	  risks	  of	   failure	  are	  analysed	  together	  the	  fear	  on	  the	  use	  of	  massive	  allografts	  is	  understandable.	  However,	  with	  a	  closer	  analysis,	  it	  is	  clear	  how	  every	  single	  element	  of	  risk	  is	  strictly	  correlated	   to	   the	   vitality	   of	   the	   graft:	   an	   allograft	   that	   cannot	   be	  incorporated	   and,	   therefore,	   remains	   constituted	   by	   dead	   bone,	   will	  have	  all	  of	  these	  risks	  which,	  moreover,	  will	  increase	  overtime.	  On	  the	  other	  hand,	  if	  a	  strategy	  to	  guarantee	  early	  re-­‐vascularization	  and	  re-­‐vitalization	   of	   the	   graft	   is	   found,	   all	   these	   risks	   will	   decrease	   and	  potentially	   disappear,	   and	   this	   will	   greatly	   improve	   the	   treatment	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options	  that	  can	  be	  offered	  to	  patients	  with	  bone	  tumors.	  It	  is	  evident,	  therefore,	   how	   a	   technique	   to	   allow	   bone	   allograft	   re-­‐vitalization	  could	  potentially	  represent	  an	   ideal	  solution	   for	   these	  patients	  and	  a	  valid	  option	  to	  prosthetic	  replacements.	  	  
1.3	   PLASTIC	  SURGERY	  AND	  RECONSTRUCTIVE	  MICROSURGERY	  IN	  MUSCULO-­‐SKELETAL	  ONCOLOGY	  
When	  the	  tumor	  involves	  the	  soft	  tissues	  (muscles,	  ligaments	  and	  tendons,	   adipose	   tissue,	   skin),	   there	   are	   mainly	   two	   strategies	   of	  wound	   closure	   after	   the	   resection:	   1.	   Primary	   closure.	   2.	   Plastic	  reconstruction,	   from	   simple	   skin	   grafts	   to	  more	   complex	   techniques	  such	  as	  free	  or	  rotational	  flaps.	  The	  indications	  depend	  on	  the	  amount	  of	  tissue	  that	  needs	  to	  be	  replaced,	  the	  available	  skin	  coverage	  and	  the	  necessity	  or	  not	  to	  cover	  prosthesis	  or	  allografts.	  	  	  -­‐ SOFT	  TISSUE	  RECONSTRUCTIONS	  	  
In	  many	  cases,	  when	  the	  tumor	  involves	  muscles	  or	  subcutaneous	  tissue,	   there	   is	   the	   chance	   for	   the	  orthopaedic	   surgeon	   to	   suture	   the	  wound	   without	   the	   need	   of	   the	   plastic	   surgeon.	   This	   happens	   only	  when	   the	   resection,	   being	   wide,	   is	   still	   limited	   and	   allows	   a	  satisfactory	   closure	   of	   the	   skin	   flaps	  without	   excessive	   tension.	   As	   a	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general	   rule,	   the	   main	   goal	   of	   the	   wound	   closure,	   is	   to	   re-­‐suture	  muscular	   groups	   with	   the	   same	   function	   or,	   in	   general,	   without	   an	  opposition	  function.	  In	  many	  cases,	  a	  substantial	  portion	  of	  the	  muscle	  where	   the	   lesion	  was	   has	   been	   resected,	   leaving	   the	   surgeon	  with	   a	  small	   fragment	   of	   tissue	   that	   helps	   only	   as	   “gap	   filler”.	   Usually,	   the	  function	   of	   the	   limb	   is	   severely	   impaired,	   because	   there	   is	   no	  reconstruction	   of	   the	   functional	   units	   lost	   with	   the	   resection,	   and	  other	  muscles,	  with	  time,	  tend	  to	  hypertrophy	  to	  partially	  replace	  the	  lost	   function.	   In	   addition	   to	   this,	   aesthetic	   is	   also	   compromised	  because	  of	  asymmetry	  with	  the	  contra-­‐lateral	  side	  and	  “depression”	  at	  the	   level	   of	   the	   resection.	   In	   many	   cases	   this	   is	   only	   a	   minimal	  discomfort	   for	   the	   patient,	   but	   sometimes,	   in	   areas	   such	   as	   the	  adductor	   compartment	   of	   the	   thigh,	   following	   the	   resection	   an	  abundant	  seromatous/haematic	  collection	  follows	  (56).	  	  Plastic	   reconstructive	   surgery	   is	   the	   solution	  when	   the	   defect	   is	  too	  big	  to	  be	  covered	  with	  primary	  closure;	  plastic	  techniques	  allow	  a	  more	  accurate	  anatomic	  reconstruction,	  usually	  with	  a	  better	  accepted	  aesthetic	   results	   (57-­‐59).	   Plastic	   reconstructive	   techniques	   are	  numerous	  and	  depend	  on	  the	  size	  of	  the	  defect,	  the	  area	  that	  needs	  to	  be	   replaced,	   the	   amount	   of	  muscle	   that	   has	   to	   be	   replaced,	   and	   the	  quality	   of	   the	   skin.	   In	   the	   case	   of	   big	   sarcoma	   resections,	   typically	   a	  free	   or	   rotational	   muscolo-­‐cutaneous	   flap	   is	   the	   surgeon’s	   choice	  because	   it	   provides	   adequate	   coverage	   despite	   the	   bulkiness	   that	  sometimes	  remains	  at	  the	  level	  of	  the	  flap	  (60).	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  -­‐ FREE	  FLAPS	  IN	  SARCOMA	  SURGERY	  	  The	   use	   of	   free	   or	   rotational	   flaps	   is	   an	   extremely	   valuable	  resource	   in	   soft	   tissue	   reconstruction;	   in	   the	  most	   recent	   years,	   the	  use	  of	  this	  type	  of	  flaps	  is	  not	  anymore	  restricted	  to	  the	  cases	  in	  which	  there	   is	   the	   necessity	   to	   cover	   the	   prosthetic	   or	   biologic	   bone	  reconstruction	   or	   in	   cases	   in	   which	   the	   primary	   closure	   cannot	   be	  achieved.	  In	  fact,	  the	  use	  of	  flaps	  has	  became	  more	  and	  more	  common	  in	   sarcoma	   reconstruction,	   with	   particular	   indications	   in	   which,	  despite	  the	  possibility	  of	  a	  primary	  closure,	  a	  flap	  is	  preferred	  because	  of	   the	   decrease	   of	   post-­‐operative	   complications.	   This	   is	   the	   case,	   for	  example,	  of	   the	   lesions	   in	   the	  adductor	  compartment	  of	   the	   thigh.	   In	  this	   area,	   in	   fact,	   a	   wide	   excision	   of	   the	   lesion	   often	   ends	   with	   the	  neurovascular	  bundle	  isolated	  and	  dissected	  free	  of	  the	  lesion	  and	  of	  the	  muscles;	   even	  when	   the	   primary	   closure	   is	   achievable,	   the	   large	  empty	  space	  and	  the	  loss	  of	  the	  lymphatic	  drainage	  together	  with	  a	  big	  number	   of	   the	   venous	   branches,	   brings	   to	   the	   formaton	   of	   a	   large	  haematoma/seroma	   which	   cannot	   be	   promptly	   re-­‐absorbed	   by	   the	  body	   with	   a	   severe	   increased	   rick	   of	   post-­‐operative	   infection	   (56).	  Furthermore,	   the	   radiation	   therapy	  given	  preoperatively	  will	  modify	  the	   quality	   of	   the	   surrounding	   tissues,	   with	   a	   high	   prevalence	   of	  fibrosis	   and	   a	   further	   decrease	   of	   the	   ability	   to	   re-­‐absorb	   the	  collection.	   In	   a	   second	   time,	   this	   collection	   eventually	   tends	   to	  organize	   and	   becomes	   harder,	   and	   the	   differential	   diagnosis	   with	   a	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recurrence	   results	   difficult,	   with	   an	   understandable	   stress	   for	   the	  patient	  and	  the	  clinician.	  Being	  able	  to	  avoid	  this	  post-­‐operative	  trend	  is	   of	   paramount	   importance,	   therefore	   very	   often	   now	   a	   free	   or	  transposed	   flap	   is	   the	   reconstruction	   of	   choice	   when	   the	   lesion	   is	  localized	   in	   that	   area	   or	   in	   areas	   with	   similar	   outcomes.	   Musculo-­‐cutaneous	  flaps,	  in	  fact,	  not	  only	  have	  the	  ability	  to	  fill	  the	  space	  with	  autogenous	  tissue,	  but,	  being	  vascularized,	  can	  guarantee	  the	  survival	  of	  the	  tissue	  and	  the	  decrease	  of	  the	  morbidities	  (Fig.	  4)	  Various	  techniques	  are	  available	  to	  the	  plastic	  surgeon	  when	  there	  is	   the	   need	   to	   fill	   the	   empty	   space	   following	   tumor	   resection.	   In	  general,	   a	  muscolo-­‐cutaneous	   flap	   is	   the	  most	  common	  method	  used	  in	   this	   type	   of	   reconstruction	   (61).	   The	   flap	   can	   be	   rotated	   from	   an	  adjacent	  area	  (as,	  for	  example,	  in	  the	  gastrocnemius	  rotation	  to	  cover	  the	   proximal	   tibia	   mega-­‐prosthesis),	   or	   can	   be	   removed	   from	   a	  different	  part	  of	  the	  body	  and	  positioned	  where	  necessary	  (free	  flap).	  This	  last	  scenario	  is	  one	  of	  the	  most	  common.	  The	  most	  used	  free	  flaps	  are:	   parascapular,	   gracilis	   and	   TRAM	   (transverse	   rectus	   abdominis	  muscle)	  (62).	  To	  survive,	  the	  free	  flaps	  need	  to	  be	  secured	  to	  an	  artero-­‐vascular	  pedicle	  with	  micro-­‐anastomosis	  at	  the	  level	  of	  the	  vascular	  bundle	  in	  the	  recipient	  area,	  through	  termino-­‐terminal	  anastomosis,	  or,	  when	  a	  major	  vessel	   is	   involved,	   through	  a	   termino-­‐lateral	   anastomosis.	  The	  ability	   of	   the	   micro-­‐surgeon	   to	   perform	   these	   sutures	   is	   extremely	  important	   for	   the	   success	   of	   the	   procedure,	   because	   if	   these	   fail	   the	  flap	  will	  not	  survive	  and	  a	  new	  procedure	  will	  be	  necessary.	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Fig.	  4	  	  Example	  of	  post	  radiotherapy	  soft	  tissue	  sarcoma	  in	  a	  42	  yo	  man	  located	  in	  
the	  antero-­‐lateral	  compartment	  of	  the	  lower	  leg.	  The	  wide	  resection	  lead	  to	  
important	  muscle	  sacrifice,	  with	  extensive	  soft	  tissue	  loss	  and	  bone	  exposure.	  
Note	   in	  quadrant	  3	   the	   inner	  margin	  of	   the	  resection,	   showing	   the	  healthy	  
muscle	  covering	  the	  lesion.	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-­‐ VASCULARIZED	   FLAPS	   AND	   THE	   ROLE	   OF	   INNERVATED	  RECONSTRUCTIONS	  
	  Musculo-­‐cutaneous	  flaps	  are	  therefore	  a	  very	   important	  resource	  for	   the	   reconstruction,	   however	   the	   implanted	   muscle	   is	   not	  functional.	  When	  a	  large	  soft	  tissue	  lesion	  is	  excised,	  together	  with	  the	  tumor	  a	  large	  amount	  of	  muscle	  is	  lost	  because	  has	  been	  replaced	  by	  the	   sarcoma	   or	   because	   its	   resection	   is	   required	   to	   obtain	   wide	  margins.	   This	   functional	   unit	   cannot	   be	   reconstructed	   with	   a	  traditional	   flap,	  because	  the	  muscle	   that	   is	  re-­‐implanted	  will	  be	  alive	  but	   not	   functional.	   In	   many	   cases	   this	   represents	   a	   minor	   problem,	  because	   other	   fellow	  muscles	   can	   partially	   replace	   the	   lost	   function,	  but	  when	  the	  major	  component	  of	  a	   joint	  mechanism	  is	   lost,	  such	  as,	  for	   example,	   the	   entire	   extensor	   mechanism	   of	   the	   knee,	   then	   the	  possibility	   of	   having	   a	   functional	   reconstruction	   becomes	   very	  appealing	  	  In	  the	  case	  of	  the	  anterior	  compartment	  of	  the	  thigh,	  in	  fact,	  a	   wide	   excision	   usually	   involves	   the	   complete	   loss	   of	   the	   knee	  extensors	   (quadriceps)	  which	   act	   as	   knee	   stabilizers	   as	  well;	   in	   this	  situation	   the	   patient	   is	   not	   able	   to	   put	   weight	   on	   the	   affected	   limb	  without	   an	   appropriate	   support	   which	   stabilizes	   the	   knee	   in	  extension.	  It	   is	   clear,	   therefore,	   how	   important	   is	   to	   find	   new	   advanced	  techniques	   for	   soft	   tissue	   reconstructions	   which	   allow	   not	   only	   the	  coverage	  of	  the	  defect	  with	  viable	  tissue,	  but	  even	  the	  ability	  to	  re-­‐gain	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at	  least	  partially	  the	  lost	  function	  in	  order	  to	  achieve	  the	  best	  possible	  outcome.	  	  Recently,	  advances	  in	  plastic	  reconstruction	  techniques	  lead	  to	  the	  development	   of	   a	   new	   procedure	   that	   will	   permit	   not	   only	   the	  anatomical	  filling	  of	  the	  defect	  with	  vital	  tissue,	  but	  the	  function	  of	  this	  tissue	  in	  synergy	  with	  the	  other	  muscles	  around.	  The	  innervated	  free	  flap,	   in	   fact,	   is	  a	   free	   flap	   that	   is	  harvested	  not	  only	  with	   its	  vascular	  pedicle,	  but	  even	  with	  its	  nerve	  pedicle	  for	  motor	  function.	  Therefore,	  once	   positioned,	   these	   flaps	   can	   be	   connected	   to	   the	   nerve	   that	   has	  been	  resected	  during	   the	   tumor	  procedure	  and,	  hence,	   thanks	   to	   the	  reinsertion	   into	   the	   remaining	   muscle	   or	   directly	   into	   the	  bone/prosthesis,	  these	  flaps	  recover	  their	  contractile	  mechanism	  and	  can	  improve	  the	  patient	  functional	  outcome.	  	  Innervated	  flaps	  have	  been	  attempted	  for	  the	  first	  time	  in	  animal	  studies	   by	   Tamai	   in	   1970	   (63),	   where	   the	   feasibility	   of	   free	  neurovascular	  muscle	  transplantation	  has	  been	  showed.	  These	  studies	  began	   the	   era	   of	   microvascular	   flap	   innovation,	   and	   since	   then	   few	  other	   reports	   described	   this	   technique	   in	   clinical	   situations.	   In	  orthopaedic	   surgery,	   innervated	   flaps	   has	   been	   used	   for	   sensate	  reconstruction	  of	  the	  heel	  and	  the	  ankle,	   in	  which	  the	  medial	  plantar	  flap	   has	   been	   used	   (64),	   and	   has	   been	   shown	   to	   be	   a	   versatile	   flap	  capable	   of	   providing	   immediate	   sensate	   coverage	   for	   heel	   and	   ankle	  defects.	   Rigorous	   neurologic	   testing	   has	   shown	   that	   when	   carefully	  dissected	  with	   preservation	   of	   its	   sensory	   branch,	   normal	   sensation	  can	   be	   readily	   maintained	   throughout	   the	   flap.	   In	   general,	   sensate	  
	   26	  
innervated	  flaps	  has	  been	  used	  for	  foot	  and	  hand	  reconstructions	  with	  different	   results	   (65,	   66),	   and	   it	   has	   been	   demonstrated	   that	   while	  reinnervating	   a	   muscle	   flap	   with	   a	   sensory	   nerve	   will	   permit	  reinnervation	  of	   the	  muscle	   and	   the	  overlying	   skin,	   it	   is	   still	   unclear	  whether	  this	  provides	  a	  superior	  result	  in	  durability	  and,	  in	  the	  case	  of	  the	  foot,	  gait	  (67).	  On	   the	  other	  hand,	   there	   is	  not	  a	  wide	   literature	  with	   regards	   to	  motor	  innervated	  flaps	  for	  the	  restoration	  of	  a	  muscle	  function	  rather	  than	  sensation.	  In	  sarcoma	  surgery,	  this	  would	  be	  the	  main	  goal	  after	  the	  resection	  of	  the	  mass,	  especially	  when	  it	  involves	  muscular	  groups	  important	  for	  ambulation,	  such	  as	  the	  extensor	  mechanism	  of	  the	  knee	  or	   the	   hip,	   or	   when	   it	   involves	   the	   upper	   limb	   and	   the	   daily	   living	  activities.	  The	  first	  case	  reports	  have	  been	  presented	  started	  form	  the	  mid	   90s,	   describing	   the	   use	   of	   free	   muscle	   transplantation	   for	   the	  reconstruction	   of	   the	   anterior	   compartment	   of	   the	   thigh	   (68),	   and	  more	  recently	  the	  surgical	  technique	  has	  been	  throughoutly	  described	  (69).	   Starting	   from	   the	   reconstruction	   of	   the	   quadriceps,	   more	  muscular	   functions	   have	   been	   proposed	   to	   be	   restored	   with	   this	  technique,	  and	  in	  1999	  Ihara	  described	  the	  use	  of	  innervated	  flaps	  for	  reconstruction	  after	   resection	  of	   soft	   tissue	   sarcomas	  achieving	  very	  good	   aesthetic	   and	   functional	   results	   (70,	   71).	   This	   procedure,	  although	  complex	  and	  time	  expensive,	  is	  very	  promising	  in	  the	  view	  of	  improving	   as	   much	   as	   possible	   the	   outcome	   in	   limb	   salvage	  procedures,	  and	  is	  the	  focus	  of	  the	  second	  part	  of	  this	  thesis.	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  1.4	   TISSUE	  ENGINEERING	  IN	  ORTHOPAEDICS	  	   	  	   Tissue	   Engineering	   is	   a	   branch	   of	   Regenerative	   Medicine	   that	  involves	   the	   creation	   of	   an	   organ	   or	   a	   tissue	   in	   laboratory,	   and	   its	  subsequent	  transplant	  in	  vivo.	  	  Musculoskeletal	   tissues,	   such	   as	   bone	   and	   cartilage,	   are	   since	  many	   years	   the	   focus	   of	   a	   very	   wide	   number	   of	   studies	   in	   tissue	  engineering,	   because	   they	   represent	   a	   relatively	   “easy”	   tissue	   to	  reproduce	  in	  laboratory	  and	  with	  a	  very	  large	  clinical	  demand.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Fig.	  5	  Representation	  of	  Stem	  Cells	  and	  their	  possibilities	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The	   cells	   derived	   from	   the	   bone	   marrow	   with	   proliferative	  capacity	   toward	   the	   mesenchymal	   lineage	   are	   called	   Mesenchymal	  Stem	  Cells	   (MSC)	  and	  are	  considered	  multipotent	  cells.	  Multipotency	  represents	   the	   characteristic	   of	   these	   cells	   to	   reproduce	   themselves	  and,	   at	   the	   same	   time,	   to	   differentiate	   toward	   a	   selective	   lineage	   for	  different	  tissue	  and	  organs	  (Fig.	  5).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Fig	  6.	  Differentiation	  abilities	  of	  MSC	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By	   using	   special	   culture	   media	   with	   selected	   growth	   factors,	  these	   cells	   have	   the	   ability	   to	   grow	   and	   to	   become	  more	   and	  more	  differentiated	  toward	  the	  chosen	  lineage	  (Fig.	  6).	  	  When	  osteogenic	  growth	  factors	  are	  chosen,	  for	  example,	  these	  cells	   after	   few	   passages	   in	   culture	   start	   to	   loose	   their	   proliferative	  capacity	  and	  gain	  the	  ability	  to	  differentiate	  themselves,	  and	  therefore	  become	   progressively	   osteoblasts	   and	   finally	   osteocytes	   with	   the	  capacity	   to	   produce	   bone	   matrix	   and	   mineralize.	   With	   this	  progression,	   the	   more	   the	   cells	   are	   moving	   towards	   the	   end	   of	   the	  differentiating	   line,	   the	   more	   they	   lose	   the	   ability	   to	   replicate	  themselves.	   On	   the	   other	   hand,	   when	   the	   cells	   are	   in	   a	   very	  undifferentiated	   status,	   they	   theoretically	   can	   replicate	  with	   no	   end.	  Growth	   factors	   used	   in	   laboratory	   to	   promote	   differentiation	   are	  chemical	   constituent	   that	   act	   by	   miming	   the	   function	   of	   autologous	  growth	   factors;	   it	   is	  however	  possible	   to	  use	  directly	   the	  autologous	  growth	  factors	  when	  they	  are	  collected	  from	  the	  cells	  that	  biologically	  constitutes	  their	  origin	  and	  their	  reservoir.	  With	   respect	   to	   osteogeneic	   tissue,	   the	   most	   used	   growth	  factors	  are	  the	  ones	  harvested	  from	  platelets,	  such	  as	  Platelet	  Derived	  Growth	   Factor	   (PDGF)	   and	   Transforming	   Growth	   Factor	   β	   (TGF-­‐β).	  While	   platelets	   are	   obtained	   from	   the	   peripheral	   blood	   and	  subsequent	   centrifugation	   and	   exclusion	   of	   the	   red	   component,	   to	  obtain	  Mesenchymal	   Stem	   Cells	   (MSC)	   a	   bone	  marrow	   aspiration	   is	  necessary	  because	  they	  are	  one	  of	  the	  component	  of	  the	  red	  marrow.	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It	  is	  well	  demonstrated	  now	  that	  MSC	  are	  found	  not	  only	  in	  the	  bone	  marrow,	  but	  potentially	  in	  every	  tissue,	  because	  it	  is	  postulated	  that	  in	  each	  tissue	  there	  is	  a	  reservoir	  of	  progenitor	  cells	  (72-­‐74).	  This	  has	  been	  specifically	  demonstrated	  in	  adipose	  tissue,	  which	  currently	  represents	  a	  widely	  used	  source	  of	  MSC	  (called	  Adipose	  Derived	  Stem	  Cells,	  ADSC)	  especially	  because	  of	  the	  simplicity	  of	  the	  harvest	  and	  the	  consistency	  of	  the	  results	  (75-­‐77).	  Stem	  cells,	  as	  specified	  before,	   regardless	  of	   their	  origin,	  when	  cultured	   in	   vitro	   with	   osteogenic	   media,	   can	   differentiate	   and	  transform	   themselves	   in	   cells	   forming	   bone	   (78,	   79).	   To	   make	   this	  process,	  growth	  factors	  and	  cells	  are	  not	  enough;	   in	   fact,	   there	   is	   the	  necessity	   of	   a	   third	   element	   that	   allows	   cells	   to	   growth	   in	   a	   3D	  construct,	  which	  represents	  the	  in	  vivo	  structure	  that	  they	  will	  need	  to	  reproduce	   (80).	   The	   third	   element	   is	   a	   scaffold,	   which	   act	   as	   a	  tridimensional	   support	   for	   the	   proliferation	   and,	   at	   the	   same	   time,	  direct	  the	  differentiation	  toward	  the	  correct	   line.	  Many	  materials	  can	  be	  used	  as	  scaffolds,	  going	  from	  simple	  organic	  fluid	  such	  as	  collagen,	  to	   more	   complex	   3D	   structures	   constructed	   with	   highly	   advanced	  technology,	   such	   as	   nano-­‐materials.	  With	   respect	   to	   bone,	  materials	  that	   can	   possibly	   be	   used	   as	   scaffolds	   need	   to	   have	   specific	  characteristics	  such	  as:	  a	  strength	  modulus	  similar	  to	  bone,	  adequate	  porosity,	   biocompatibility	   and	   the	   ability	   to	   function	   as	  osteoconductive	  and	  osteoinductive	  material.	  Some	  of	   the	  most	  used	  scaffolds	   used	   in	   laboratory	   are	   Hydroxyapatyte,	   Ceramic,	   Poly-­‐α-­‐hydroesters	   and	   other	   natural	   polymers	   as	   collagen	   and	   Chitosan.	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Fig.	   7	   	   Scaffold,	   Cells	   and	   Growth	   Factors	   are	   the	   3	   fundamental	  
element	   in	   every	  tissue	  engineering	  process.	  With	  an	  adequate	  
substrate	   and	   environment	   the	   final	   outcome	   is	   the	  
achievement	   of	   the	   two	   most	   important	   processes	   in	   bone	  
regeneration:	  osteo-­‐induction	  and	  osteo-­‐conduction	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Fig.	   8	   	   The	   three	   elements	   together	   (left	   of	   the	   picture),	   when	   in	  
adequate	  culture,	  can	  create	  a	  tissue	  that	  is	  suitable	  for	  bone	  
reconstruction	  and,	  ideally,	  after	  implantation,	  can	  reproduce	  
healthy	  bone.	  	  
	  	  	  	  	  	  	  	  1.4.1	   	   Tissue	   Engineering	   for	   bone	   reconstruction	   after	   tumor	  resection	  	   Massive	   bone	   allografts	   are	   widely	   used	   in	   orthopedic	  reconstructive	   surgery	   to	   replace	   bone	   defects	   due	   to	   trauma	   or	  oncologic	   resections.	   The	   effectiveness	   of	   the	   clinical	   outcome	  depends	  on	  bone	  healing	  time	  and	  type	  of	  graft–host	  integration:	  the	  larger	   the	   amount	   of	   bone	   to	   be	   replaced,	   the	   more	   difficult	   the	  integration	  process	  becomes	  (81).	  This	  process	  may	  involve	  only	  20%	  of	  the	  graft	  in	  5	  years,	  as	  shown	  by	  studies	  on	  retrieved	  allografts	  (82,	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83).	   In	   these	  studies	   it	  was	  shown	  that	  revascularization	  plays	  a	  key	  role	   to	   achieve	   good	   allograft	   repair:	   a	   delay	   or	   absence	   in	  revascularization	  may	   impair	   new	  bone	   formation	   and	   influence	   the	  implant	  outcome.	  Therefore,	  accelerating	  and	   increasing	  this	  process	  may	  be	  critical	  to	  allow	  bone	  healing	  and	  integration.	  Numerous	  techniques	  have	  been	  proposed	  in	  order	  to	  increase	  the	   revascularization,	   and	   therefore	   the	   regeneration,	   of	   a	   bone	  allograft.	  These	  include	  the	  use	  of	  stem	  cells,	  the	  use	  of	  growth	  factors	  (such	  as	  BMPs),	  or	  the	  combination	  of	  the	  two.	  Bone	   morphogenetic	   proteins	   (BMPs)	   are	   a	   family	   of	  pleiotrophic	   factors,	  members	   of	   the	   Transforming	   Growth	   Factor	   β	  super	   family	   (TGF-­‐β),	   that	   can	   influence	   the	  migration,	   proliferation,	  and	   differentiation	   of	   bone	   progenitors	   cells	   (84).	   It	   was	   postulated	  that	  the	  addition	  of	  BMPs	  to	  an	  allograft	  could	  increase	  its	  integration	  with	   the	  host	  bone	  by	   increasing	   the	  vascularization.	  Several	   studies	  demonstrated	   new	   bone	   formation	   when	   OP-­‐1	   alone	   or	   in	  combination	   with	   bone	   marrow	   is	   added	   to	   the	   allograft	   (85-­‐88).	  BMP-­‐2,	  BMP-­‐3,	  and	  BMP-­‐7	  have	  osteoinductive	  capacity	  in	  vitro	  and	  in	  vivo.	  In	  particular,	  BMP-­‐7,	  also	  known	  as	  OP-­‐1,	  has	  been	  shown	  to	  be	  able	   to	   accelerate	  bone	   remodeling,	   thanks	   to	   its	   osteoinductive	   and	  osteoconductive	   characteristics	   (89,	   90).	   However,	   some	   authors	  reported	  that	  BMPs	  are	  able	  to	  up-­‐	  regulate	  osteoclast-­‐like	  activity	  in	  vitro,	  thus	  leading	  to	  a	  higher	  allograft	  porosity	  and	  resorption	  when	  BMPs	  are	  added	  to	  a	  massive	  bone	  allograft	  in	  vivo	  (55,	  85,	  91,	  92).	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Bone	   marrow	   contains	   limited	   amount	   of	   subpopulation	   of	  plastic-­‐adherent,	  fibroblast-­‐like	  osteoblast	  progenitor	  cells,	  commonly	  referred	  as	  mesenchymal	  stem	  cells	  (MSCs)	  (93-­‐95).	  MSCs	  are	  used	  in	  regenerative	   medicine	   to	   repair	   bone,	   due	   to	   their	   ability,	  demonstrated	   both	   in	   vitro	   and	   in	   vivo,	   to	   differentiate	   into	   active	  osteoblasts	  (96,	  97).	  MSCs	  isolated	  from	  the	  mononuclear	  cell	  fraction	  after	   separation	   by	   density	   gradient	   centrifugation	   can	   be	   expanded	  ex	  vivo	   to	  reach	  clinically	  relevant	  numbers.	   It	  was	  demonstrated	  by	  pre-­‐	   clinical	   and	   clinical	   studies	   that	   MSCs	   can	   induce	   bone	   repair	  when	  associated	  with	  natural	  and	  synthetic	  biomaterials	  (98-­‐104).	  	  	  1.4.2.	  Tissue	  Engineering	  for	  soft	  tissue	  reconstruction	  	  Plastic	   surgical	   techniques	   continue	   to	   evolve	   to	   deal	   with	  problematic	   wounds	   following	   soft	   tissue	   sarcoma	   resection.	  Important	   advances	   in	   how	   tissue	   is	   transferred	   have	   allowed	  most	  wounds	  to	  be	  closed	  following	  extirpation;	  the	  emphasis	  is	  now	  placed	  on	   refining	   these	   transfers	   while	   minimizing	   donor	   site	   injury.	  Reconstructive	  microsurgery	   has	   emerged	   as	   a	   frequently	   preferred	  way	   to	   resurface	   wounds	   after	   sarcoma	   resection,	   particularly	   in	  patients	   who	   have	   received	   radiotherapy	   or	   previous	   surgery.	   Free	  flaps	  provide	  well-­‐vascularized	  tissue	  to	  fill	  dead	  space,	  cover	  exposed	  vital	   structures,	   and	   provide	   structural	   support	   and	   contour.	   These	  procedures	   demonstrate	   a	   high	   success	   rate	   of	   over	   90%	   and	   often	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can	  ensure	  a	  healed	  wound	  in	  a	  single-­‐stage	  operation	  (59,	  62,	  105).	  Creative	   use	   of	   the	   versatile	   rectus	   abdominis	   or	   latissimus	   dorsi	  myocutaneous	   flaps	   can	   reconstruct	   the	   majority	   of	   extremity,	   and	  head	  and	  neck	  soft	  tissue	  defects.	  Endoscopic	  harvest	  of	  muscle	  flaps	  has	  minimized	  donor	  morbidity	  and	  scarring.	  The	  use	  of	  "fillet	  flaps"	  is	  an	  important	  concept	  that	  spares	  a	  patient	  donor	  site	  (60,	  106,	  107).	  The	   future	   holds	   great	   promise	   for	   sarcoma	   reconstruction	   because	  tissue	   engineering	   is	   rapidly	   closing	   in	   on	   techniques	   that	   can	  duplicate	  tissues	  in	  the	  laboratory	  for	  ultimate	  use	  in	  reconstruction,	  thus	  sparing	   the	  donor	  site	   from	  disease	   (59).	   In	  2007	  a	  group	   from	  Singapore	   has	   proposed	   to	   combine	   tissue-­‐engineering	   techniques	  together	   with	   flap	   prefabrication	   techniques	   to	   generate	   a	  prefabricated	  vascularized	  soft	  tissue	  flap	  in	  the	  nude	  mice.	  They	  have	  demonstrated	   that	   PLGA-­‐c	   scaffolds,	   enveloped	   by	   a	   cell	   sheet	  composed	  of	  fibroblasts,	  can	  serve	  as	  a	  suitable	  scaffold	  for	  generation	  of	   a	   soft	   tissue	   flap.	   A	   ligated	   arteriovenous	   pedicle	   can	   serve	   as	   a	  vascular	  carrier	  for	  the	  generation	  of	  a	  tissue	  engineered	  vascularized	  flap	   (108).	   In	   more	   recent	   experimental	   studies,	   promising	   new	  method	   of	   generating	   significant	   amounts	   of	   mature,	   vascularized,	  stable,	  and	  transferable	  adipose	  tissue	  for	  permanent	  autologous	  soft-­‐tissue	  replacement	  have	  been	  shown,	  although	   this	  still	   represents	  a	  future	  prospective	  (109).	  While	   tissue	   engineering	   techniques	   for	   soft	   tissue	  reconstruction	  are	  under	  study,	   there	   is	   the	  need	  for	  more	  advanced	  clinical	  techniques	  to	  improve	  the	  quality	  of	  the	  constructs.	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The	  goal	  of	  this	  thesis	  is	  to	  improve	  the	  outcome	  of	  the	  current	  reconstructive	  therapies	  for	  bone	  and	  soft	  tissue	  pathologies	  applying	  tissue	   engineering	   strategies.	   This	   thesis,	   therefore,	   combines	   two	  projects	  that	  cover:	  
1. Bone	  regenerative	  and	  reconstructive	  techniques	  2. Soft	  tissue	  microsurgical	  reconstructive	  strategies	  	  	  	  
2.1	  Bone	  regenerative	  and	  reconstructive	  techniques	  
	   	  
The	   goal	   of	   this	   project	   is	   to	   improve	   the	   outcome	   of	  massive	   bone	  allograft	   reconstruction	   after	   diaphyseal	   tumor	   resection.	   After	   the	  encouraging	  results	  of	  our	  previous	  study	  in	  the	  large	  animal	  with	  the	  use	  of	  non-­‐vascularized	  allograft	  added	  with	  MSC	  and	  OP-­‐1,	  the	  main	  goal	   of	   this	   experiment	   is	   to	   obtain	   a	   re-­‐vascularization	   of	   the	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allograft.	   In	   our	   previous	   study	   (110)	   we	   have	   demonstrated	   the	  superiority	  of	  ADSC	  and	  OP-­‐1	  added	  to	  the	  allograft	  compared	  to	  the	  allograft	  alone	  in	  the	  graft	  regeneration	  and	  integration.	  However,	  the	  amount	   of	   new	   bone	   formation	   in	   the	   allograft	   remained	   un-­‐satisfactory.	  The	  addition	  of	  an	  artero-­‐venous	  bundle	  inside	  the	  canal	  would	  permit	  the	  early	  re-­‐vascularization	  of	  the	  allograft,	  allowing	  the	  survival	   of	   the	   implanted	   stem	   cells	   and	   the	   allograft	   itself.	   This,	   in	  theory,	   would	   end	   in	   a	   graft	   that	   can	   be	   revitalized	   and	   eventually	  completely	   replaced	   by	   host	   bone,	  which	  will	   substantially	   decrease	  the	   amount	   of	   possible	   allograft	   complications.	   Therefore,	   the	   main	  goal	  of	  this	  project	  is	  to	  accelerate	  and	  improve	  the	  regeneration	  of	  a	  massive	   bone	   allograft	   through	   the	   insertion	   of	   a	   vascular	   bundle	  which	  should	  guarantee	  the	  early	  and	  direct	  	  re-­‐vascularization	  of	  the	  implant.	  
	  
	  
2.2	   Soft	   tissue	   microsurgical	   reconstructive	   strategies	   after	   tumor	  resections	  
	   	  
The	   quality	   of	   microsurgical	   plastic	   techniques	   for	   soft	   tissue	  reconstruction	   has	   improved	   dramatically	   over	   the	   past	   years.	   The	  goal	   of	   this	   clinical	   part	   of	   thesis	   is	   to	   obtain	   satisfactory	   functional,	  together	   with	   aesthetical,	   reconstruction	   after	   resection	   of	   main	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muscle/tendon	   for	   tumor.	   This	   will	   be	   achieved	   using	   motor	   re-­‐innervated	  free	  flaps	  that	  should	  allow	  the	  flap	  to	  sustain	  the	  function	  of	  the	  resected	  muscle(s)	  and/or	  tendon(s).	  
To	   our	   knowledge	   this	   is	   the	   first	   study	   that	   evaluates	   the	  functional	   outcome	   of	   innervated	   muscle	   transfer	   in	   the	   setting	   of	  irradiated	  limbs	  for	  soft	  tissue	  sarcomas.	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3.	  BONE	  REGENERATION	  PROJECT	  
	  
	  
3.1	  Background	  	  
	  
Bone	  allografts	  are	  widely	  used	  to	  replace	  bone	  defects	  caused	  by	   traumas	   or	   by	   surgical	   operations	   for	   congenital	   malformations,	  tumor,	   infections	   or	   prosthetic	   failures	   (51,	   55,	   81,	   111-­‐115).	   The	  incorporation	   of	   the	   allograft	   requires	   a	   cooperative	   interaction	  between	   the	   allograft	   itself	   and	   the	   host	   bone	   (116,	   117).	   The	  most	  important	   role	   in	   the	   incorporation	   process	   is	   done	   by	   the	   vascular	  bed	  which	  provides	  not	  only	  the	  cells	  responsible	  for	  the	  regeneration	  of	   this	   bone	   (MSCs),	   but	   even	   the	   fundamental	   factors	   for	   the	  maturation	   of	   these	   cells	   and	   their	   differentiation	   into	   osteoblast	  precursors	  (48,	  85,	  86,	  101,	  118,	  119).	  The	  allograft	  incorporation	  can	  therefore	   be	   seen	   as	   a	   process	   that	   involves	   both	   re-­‐vascularization	  and	   re-­‐vitalization	   at	   the	   same	   time,	   because	   these	   two	   actions	   are	  strictly	   connected	   one	   to	   each	   other.	   A	   slow	   or	   insufficient	   re-­‐vascularization	   can	   impair	   the	   implant	   incorporation	   or,	   in	   some	  cases,	   cause	   its	   failure.	   On	   the	   other	   hand,	   when	   a	   good	   re-­‐
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vascularization	   of	   the	   graft	   is	   achieved,	   the	   initial	   integration	   of	   the	  implant	   is	   shown	   by	   a	   sound	   consolidation	   at	   the	   level	   of	   the	  osteotomy	   lines,	   which,	   in	   turn,	   will	   lead	   to	   a	   satisfactory	  incorporation	  of	  the	  implant	  and	  the	  decrease	  of	  the	  risk	  of	  failure.	  
It	   is	   clear,	   therefore,	   how	   vessel	   penetration	   into	   the	   graft	  constitutes	   the	  primary	  and	  probably	  most	   important	  process	   in	   the	  allograft	  incorporation.	  The	  re-­‐vascularization	  can	  be	  achieved	  mainly	  in	   two	  ways:	  1)	   the	  effect	  of	   the	   surrounding	   tissues	  and	   structures,	  which	   stimulate	   the	   vessel	   penetration	  with	   an	   extrinsic	  mechanism	  (120-­‐122);	   or	   2)	   by	   implanting	   a	   vascular	   pedicle	   inside	   the	   graft,	  which	   directly	   brings	   the	   vascular	   supply	   together	   with	   all	   the	  nutrient	   and	   growth	   factors	   (123).	   This	   second	   mechanism	   can	  guarantee	  a	  more	  direct	  and	  secure	  method	  to	  re-­‐vascularize	  the	  graft,	  while	   the	   extrinsic	   mechanism	   tends	   to	   be	   a	   slow	   and	   incomplete	  process	  with	  a	  limited	  power.	  Together	  with	  blood	  and	  growth	  factors	  supply,	  there	  is	  the	  necessity	  to	  introduce	  progenitor	  cells,	  which	  can	  in	  turn	  act	  as	  stimulators	  for	  other	  cells	  and	  growth	  factors	  and,	   in	  a	  second	  time,	  differentiate	  themselves	  into	  bone	  forming	  cells	  (101).	  	  
The	  presence	  of	  a	  high	  number	  of	  Stem	  Cells	  into	  the	  area	  that	  need	   to	  be	   re-­‐vascularized	  and	   re-­‐generated	   is	   another	  key	   factor	   in	  the	   integration	  process:	   these	   cells,	   in	   fact,	   primarily	   act	   as	   cytokine	  producing	   elements	   which	   are	   responsible	   for	   the	   vascular	   neo-­‐formation.	   The	   Vascular	   Endothelial	   Growth	   Factor	   (VEGF),	   for	  example,	  is	  one	  of	  the	  main	  cytokine	  produced	  by	  the	  MSCs,	  and	  acts	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not	  only	  as	  a	  neo-­‐angiogenic	  factor,	  but	  even	  as	  an	  osteogenic	  factor.	  Other	  factors	  produced	  by	  the	  MSC,	  which	  have	  an	  autocrine	  effect	  as	  well,	  are	  TGF-­‐β,	  which	  act	  as	  important	  osteogenic	  factors	  (73,	  124).	  
Stem	   cells	   are	   relatively	   easy	   cells	   to	   obtain	   in	   patients	   that	  undergo	   to	  orthopaedic	  surgery	  procedures,	  as	   they	  can	  be	  obtained	  not	   only	   from	   a	   bone	   marrow	   aspirate,	   but	   even	   from	   the	   sub-­‐cutaneous	  adipose	  tissue	  (75).	  Moreover,	  these	  cells	  are	  safe	  and	  they	  do	  not	  constitute	  a	  risk	  in	  terms	  of	  rejection	  because	  they	  can	  be	  used	  as	  autogenous	  cells.	  
BMPs	   are	  members	   of	   the	   TGF-­‐β	   superfamily	  which	   has	   been	  demonstrated	  to	  play	  a	  fundamental	  role	  in	  skeletal	  formation	  both	  in	  embryonal	  growth	  and	  in	  adult	  life	  (125,	  126).	  This	  is	  true	  especially	  for	   BMP-­‐2,	   BMP-­‐4	   and	   BMP-­‐7,	   even	   if	   only	   BMP-­‐2	   and	   BMP-­‐7	   (also	  known	  as	  OP-­‐1)	  have	  demonstrated	  their	  osteo-­‐inductive	  potentiality	  in	  pre-­‐clinical	  and	  clinical	  experimental	  studies	  (91,	  119,	  127-­‐130).	  
In	  a	  bone	  regeneration	  setting	  such	  as	  delayed	  fracture,	  aseptic	  bone	   necrosis	   or	   other	   critical	   defect,	   bone	  morphogenetic	   proteins	  (BMPs)	   have	   proved	   key	   in	   enhancing	   the	   natural	   ability	   of	   the	  surrounding	  tissues	  to	  produce	  bone	  healing	  (84,	  91,	  129,	  130).	  If	  the	  mechanical	   conditions	   are	   fulfilled,	   these	   molecules	   are	   able	   to	  address	   progenitor	   cells	   in	   the	   bone-­‐forming	   cascade	   to	   allow	   the	  repair	   of	   the	   damaged	   tissue.	   It	   is	   important	   to	   underline	   also	   the	  action	  of	  single	  BMPs	  as	  well	  as	  in	  association	  with	  others	  of	  the	  BMP	  family	  group.	  It	  has	  been	  stated	  that	  BMPs	  produce	  bone	  by	  a	  complex	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series	  of	  events	  involving	  a	  subset	  of	  proteins	  all	  capable	  of	   inducing	  bone	   formation	   by	   themselves,	   including	   BMPs	   -­‐2,	   -­‐3,	   -­‐4	   and	   -­‐6.	  Concurrently	   other	   cytokines	   that	   are	   not	   BMPs	  may	   facilitate	   bone	  formation	  in	  other	  ways,	  e.g.	  FGF,	  which	  has	  an	  angiogenic	  effect	  that	  promotes	   neovascularisation,	   and	   PDGF	   and	   IGF-­‐1	   acting	   as	   local	  modulators	  (131).	  
	  
3.2	  Previous	  studies	  	  
	  
It	   is	   clear	   since	   many	   years	   that	   the	   main	   reason	   of	   allograft	  failure	   is	   its	   poor	   blood	   supply;	   therefore,	   because	   early	   vascular	  invasion	   is	   a	   key	   factor	   in	   bone	   allograft	   incorporation,	   in	   our	   very	  first	   study	  done	   in	  2005	  we	   tested	  whether	   the	   combination	  of	  MSC	  and	  platelet-­‐rich	  plasma	  (PRP)	  was	  able	  to	  increase	  vascular	  invasion	  and	  massive	  allograft	  integration	  in	  a	  large	  animal	  model	  (101).	  In	  this	  study	  we	  have	   chosen	  PRP	  because	  on	  activation,	  platelets	   release	   a	  high	   concentration	   of	   a	   variety	   of	   proteins	   including	   VEGF	   and	  fibroblast	   growth	   factor-­‐2	   (FGF-­‐2)	   (132,	   133).	   These	   molecules	  released	  by	  platelets	  are	  strong	  angiogenic	  inducers	  and	  are	  known	  to	  be	  mitogenic	   for	   the	  MSC	  (134).	   In	   this	  early	   study,	  we	  were	  able	   to	  demonstrate	  that	  MSC	  contained	  in	  a	  collagen	  and	  PRP-­‐based	  scaffold	  can	  improve	  allograft	  integration,	  even	  though	  this	  improvement	  was	  moderate	   (Fig.	   9).	   Being	   both	   MSC	   and	   PRP	   angiogenic	   factors,	   we	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moved	  to	  a	  second	  study	  in	  which	  we	  wanted	  to	  couple	  an	  osteoclastic	  activity	  to	  an	  osteoblastic	  one,	  still	  maintaining	  the	  strong	  angiogenic	  stimulation.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Fig.	   9	   	   The	   evolution	   of	   the	   healing	   process	   in	   the	   control	   and	  
study	   (MSC	   +	   PRP)	   groups	   is	   shown	   in	   radiographic	  
images.	  At	  both	   2	  and	   4	  months	   there	   is	   less	   evidence	   of	  
healing	  along	  with	  more	  periosteal	  callus	  in	  the	  proximal	  
osteotomy	   line	   	   in	   the	   control	  group,	  while	  a	  more	  direct	  
healing	  process	  is	  seen	  in	  the	  study	  group	  .	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In	  our	  subsequent	  study,	  therefore,	  using	  the	  same	  	  large	  animal	  model	  (sheep),	  we	  tested	  whether	  MSCs	  and	  OP-­‐1	  added	  to	  a	  massive	  bone	   allograft	   can	   promote	   a	   complete	   bone–allograft	   integration	  (110).	  The	  idea	  behind	  the	  project	  was	  that	  the	  regeneration	  process	  should	   be	   achieved	   by	   direct	   penetration	   of	   cutting	   cones	   at	   the	  junction	   site	   from	   the	  host	  bone	   to	   the	   allograft	   stimulated	  by	  OP-­‐1,	  together	  with	  the	  strong	  angiogenic	  activity	  promoted	  by	  this	  protein,	  thus	  reducing	   the	  amount	  of	  callus	   formation	  around	   the	   implant.	   In	  the	  meanwhile	  allograft	  bone	  should	  be	  completely	  replaced	  by	  newly	  formed	  bone	  promoted	  by	  the	  MSCs	  activity.	  	  In	   this	   study	   we	   evaluated	   the	   effect	   of	   OP-­‐1	   alone	   (BMP-­‐7),	  MSCs	   alone	   and	  OP-­‐1+MSCs	   in	   the	   allograft	   integration	  of	   a	  massive	  intercalary	   defect	   in	   the	   sheep’s	   metatarsal	   bone.	   Interestingly,	   we	  noticed	   that	   when	   OP-­‐1	   was	   used	   alone,	   the	   amount	   of	   bone	  resorption	  was	  substantially	  higher	  than	  the	  ability	  of	  the	  host	  bone	  to	  stimulate	   new	   bone	   formation,	   thus	   leading	   to	   an	   almost	   complete	  disappearance	   of	   the	   allograft	   in	   some	   cases.	   This	   high	   absorption	  activity	  can	  be	  explained	  by	  the	  strong	  stimulation	  of	  the	  osteoclastic	  activity	   by	   the	   OP-­‐1,	   without	   a	   sufficiently	   high	   coupling	   with	  osteoblastic	   activity.	  On	   the	  other	  hand,	  when	  MSCs	  where	  added	   to	  OP-­‐1,	   the	  osteoblastic	   function	  was	  strong	  enough	   to	  produce	  a	  very	  good	  amount	  of	  new	  bone	   in	   the	  area	  previously	  re-­‐absorbed	  by	   the	  osteoclasts	  (Fig	  10).	  Finally,	  when	  MSCs	  where	  used	  alone,	  the	  amount	  of	  new	  bone	  formation	  was	  minimal	  (but	  still	  higher	  compared	  to	  the	  control	   group	   with	   no	   OP-­‐1	   nor	   MSCs)	   due	   mainly	   to	   the	   limited	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activity	  of	   these	   cells	   in	   a	   contest	  where	   there	   is	  no	   absorption	  and,	  more	  importantly,	  where	  there	  is	  insufficient	  vascularization	  to	  allow	  them	  to	  survive	  enough	  time	  to	  complete	  their	  tasks.	  	  	  	  	  	  	  	  	  	  
	  	   	  This	  results	  were	  consistent	  with	  the	  findings	  of	  Cullinane	  et	  al.	  (85)	  who	  demonstrated	  a	  significant	  reabsorption	  rate	  with	  a	  massive	  bone	   allograft	   in	   a	   canine	   model	   treated	   with	   rh-­‐OP-­‐1	   at	   12	   weeks	  postoperatively.	  The	  results	  obtained	   in	  this	   further	  study	  were	  very	  similar	   to	   those	   of	   their	   previous	   study,	   confirming	   the	   high	  stimulation	  of	  graft	  reabsorption	  when	  rh-­‐BMP-­‐7	  was	  used	  (86).	  This	  
	  
Fig.	  10	  	  Schematic	  effect	  of	  OP-­‐1	  and	  MSC	  on	  bone.	  While	  OP-­‐1	  stimulates	  
osteoclastic	   activity	   and,	   thus,	   bone	   resorpition,	   MSCs,	   by	   their	  
direct	  differentiation	   into	  osteoblasts	  or	  by	  direct	   stimulation	  of	  
circulating	  cells	  to	  recruit	  osteoblasts,	  stimulate	  bone	  formation.	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concept	   was	   also	   confirmed	   by	   other	   authors	   dealing	   with	  experimental	  model	  of	   impaction	  grafting	  using	  morcellised	  allograft	  and	  BMP	  (135).	  In	  our	  previous	  study	  (110)	  we	  were	  able	  to	  demonstrate	  that	  the	   addition	   of	   MSCs	   together	   with	   OP-­‐1	   is	   able	   to	   increase	   the	  integration	   of	   a	   massive	   bone	   allograft	   with	   a	   high	   amount	   of	   new	  bone	  formation	  inside	  its	  structure	  (FIG	  11)..	  	  	  	  	  	  	  	  	  	  
	  	  
	  
Fig.	  11	   	   X-­‐Ray	  evaluation	  of	  groups	   treated	  with	  MSC	   alone,	   OP-­‐1	   alone,	  
and	   the	   combination	   of	   MSC	   and	   OP-­‐1	   at	   4	   months.	   When	   MSCs	  
were	   used	   alone,	   although	   a	   better	   bone	   integration	   was	   seen	  
compared	  to	  the	  control	  group,	  the	  osteotomy	  lines	  were	  still	  visible	  
and	   the	   integration	   occurred	   via	   external	   callus	   bridging.	   When	  
OP-­‐1	  was	  used	  alone,	  a	  great	  amount	  of	  bone	  allograft	  resorption	  
was	  evident.	  On	  the	  other	  hand,	  the	  combination	  of	  MSC	  and	  OP-­‐1	  
allowed	   a	   far	   better	   integration	   with	   a	   direct	   process	   and	  
restoration	  of	  the	  medullary	  canal	  and	  cortex	  continuity.	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The	   role	   of	   the	   timed	   coupling	   between	   bone	   reabsorption	  (osteoclasts)	   and	   bone	   formation	   (osteoblasts)	   is	   of	   paramount	  importance	   in	   bone	   tissue	   engineering.	   However,	   despite	   the	  outstanding	   improvement	   compared	   to	   the	   actual	   allograft	  incorporation	  strategies,	  this	  technique	  was	  still	  not	  powerful	  enough	  to	  obtain	  a	  complete	  allograft	  revascularization	  and	  regeneration.	  We	  believe	  that	  the	  main	  obstacle	  for	  a	  complete	  regeneration	  process	  is	  the	   lack	   of	   sufficient	   vascularization,	   which	   in	   turn	   decrease	   the	  chance	  of	  survival	  of	  the	  implanted	  stem	  cells	  The	  activity	  of	  OP-­‐1	  and	  MSC	  to	  promote	  early	  vascularization	  was	   noted	   not	   only	   on	   Xray,	   but	   even	   on	   histology,	   and	   was	  encouraging	   (Fig	   12).	   However,	   this	   re-­‐vascularization	  was	   noted	   to	  be	   still	   insufficient,	   and	   this	   probably	   was	   due	   to	   the	   extrinsic	  mechanism	  by	  which	  the	  new	  vessel	  formation	  has	  to	  develop.	  The	  idea,	  therefore,	  was	  to	  implement	  the	  vascularization	  of	  the	  graft	  with	  a	  direct	  mechanism,	  by	  implanting	  an	  artero-­‐venous	  pedicle	  within	  its	  structure,	  in	  order	  to	  achieve	  an	  early	  blood	  supply	  that	  can	  1)	   support	   the	   function	   and	   the	   survival	   of	   stem	   cells,	   and	   2)	  implement	   the	   supply	   of	   circulating	   cells,	   such	   as	   macrophages,	   to	  increase	   the	   bone	   remodelling	   thanks	   to	   their	   paracrine	   effects.	   For	  this	  purpose	  we	  developed	  a	  small	  animal	  model	   that	   is	   the	   focus	  of	  this	  first	  part	  of	  this	  thesis.	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Fig.	   12	   Histology	   images	   of	   the	   frontal	   and	   axial	   cuts	   in	   the	   four	   groups	  
(Trichromic	  Masson;	  optical	   zoom:	  1.25 ).	  Only	   the	   cortex	  opposite	  
to	   the	   plate	   side	   is	   included	   in	   the	   slices.	   In	   the	   control	   group	  
abundant	   periosteal	   callus	   was	   evident	   with	   lack	   of	   newly	   formed	  
bone	   inside	   the	   allograft	   cortex.	   In	   the	  MSC	   group	   there	  was	  more	  
rearrangement	  inside	  the	  allograft	  cortex	  with	  no	  evidence	  of	  cutting	  
cones,	  and	  marked	  periosteal	  callus.	  In	   the	  OP-­‐1	  group	  the	  allograft	  
was	  completely	  absorbed	  with	  a	  marked	  presence	  of	  woven	  bone	  and	  
bone	   remodeling.	   In	   the	   MSC	   +	   OP-­‐1	   group	   the	   bone	   remodeling	  
inside	   the	   allograft	   was	   predominant	   with	   several	   cutting	   cones	  
starting	   from	   the	  host	   cortex	   invading	   the	   grafts	   cortex.	   The	   callus	  
was	  almost	  not	  visible.	  	  	  
	   49	  
In	  a	  study	  conducted	  very	  recently	  by	  a	  German	  group	  (123)	  an	  inguinal	   artero-­‐venous	   bundle	   was	   dissected	   in	   the	   groin	   of	   female	  white	   New	   Zealand	   rabbits	   (n	   =	   6)	   and	   placed	   centrally	   inside	   a	  scaffold	  seeded	  with	  Adipose	  Derived	  Stem	  Cells	  (ADSC)	  via	  a	  central	  drill	  hole.	  In	  the	  same	  surgical	  session	  this	  construct	  was	  placed	  into	  a	  segment	   of	   a-­‐vital	   cortical	   bone	   allograft	   from	   a	   donor	   rabbit.	   Un-­‐seeded	  scaffolds	  that	  were	  implanted	  and	  treated	  in	  the	  same	  fashion	  served	   as	   controls	   (n	   =	   6).	   In	   order	   to	   prevent	   external	  revascularization,	   all	   constructs	   were	   wrapped	   in	   silicon	   foil	   and	  finally	   implanted	   in	   the	   rabbits'	   groin.	   Three	   months	   later,	   the	  constructs	  were	  explanted	  and	  investigated	  for	  vascularization	  of	  (a)	  the	   scaffold	   (b)	   the	   surrounding	   bone	   allograft.	   As	   a	   result,	   ADSC	  seeded	   scaffolds	   showed	   a	   significant	   increase	   in	   new	   vessel	  formation	  in	  the	  scaffold	  as	  well	  as	  in	  the	  bone	  allograft	  compared	  to	  un-­‐seeded	   scaffolds.	   Furthermore,	   new	   vital	   osteocytes	   as	   a	   sign	   of	  cellular	  repopulation	  inside	  the	  bone	  allograft	  were	  found	  only	  in	  the	  treatment	   group.	   Vital	   chondrocytes	   were	   only	   found	   in	   the	   ADSC	  seeded	   scaffolds	   as	   well.	   This	   study	   was	   very	   encouraging	   for	   our	  project,	  as	   it	  demonstrated	  that	   the	   introduction	  of	  an	  artero-­‐venous	  bundle	   inside	   the	   centre	   of	   a	   scaffold	   improves	   its	   revitalization;	   in	  our	   approach,	   we	   aimed	   to	   regenerate	   new	   bone	   directly	   into	   the	  defect,	  as	  it	  would	  be	  more	  reasonable	  in	  a	  clinical	  situation.	  After	  the	  design	  of	  the	  model,	  the	  introduction	  of	  stem	  cells	  coupled	  with	  Bone	  Morphogenetic	   Proteins,	   specifically	   OP-­‐1,	   should	   considerably	  implement	  the	  revitalization	  of	  a	  massive	  cortical	  allograft.	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  3.3	  Experimental	  design	  
	  
Rabbits	   were	   considered	   as	   the	   ideal	   starting	   point	   for	   our	  experimental	  project.	  These	  animals	  are,	   in	   fact,	  very	  easy	   to	  handle,	  gentle	  in	  their	  temperament	  and	  relatively	  quite	  in	  the	  post-­‐operative	  period,	  with	  a	   relatively	  good	  pain	   threshold.	  At	   the	  same	   time,	   they	  are	  economic	  to	  use	  and	  this	  characteristic	  allow	  the	  use	  of	  a	  sufficient	  number	  of	  animals	  to	  achieve	  statistically	  sound	  results	  in	  a	  relatively	  short	  amount	  of	  time.	  The	  most	  important	  limitation	  of	  this	  animal	  is	  however	  the	  poor	  transferability	  to	  the	  human	  clinical	  situation	  due	  to	  the	  anatomical	  differences	  not	  only	  as	  a	  general	  concept,	  but	  even	  in	  the	   bony	   anatomy,	   bone	   strength	   modulus	   and	   cortex/medullary	  canal	   ratio	   in	   the	   diaphisis.	   Together	   with	   this,	   even	   the	   bone	  regeneration	   physiology	   is	   different,	   and	   this	   represents	   another	  difficulty	  in	  the	  comparability	  with	  humans.	  
It	   will	   be	   therefore	   necessary	   to	   add	   a	   second	   phase	   to	   this	  preliminary	   project,	   which	   will	   involve	   the	   use	   of	   larger	   animal	  models	   that	   can	   guarantee	   a	   better	   transferability	   of	   the	   results	   to	  humans.	  This	  model	  will	  be	  the	  sheep	  metatarsal	  one,	  which	  has	  been	  proven	  to	  be	  extremely	  reliable	  and	  repeatable	  in	  our	  hands.	  
In	   this	   preliminary	   project	  we	   used	   16	   rabbits;	   there	  was	   the	  need	  to	  use	  4	  of	  these	  animals	  to	  test	  the	  model,	  for	  two	  main	  reasons:	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1)	   it	   was	   the	   first	   time,	   in	   our	   hand,	   that	  we	   created	   an	   intercalary	  massive	   defect	   in	   the	   femur	   of	   the	   rabbit,	   and	  2)	   in	   all	   the	   previous	  publications	   where	   a	   femoral	   diaphyseal	   defect	   was	   created,	   the	  fixation	  method	   chosen	  was	   an	   intra-­‐medullary	   pin.	   In	   our	   case	   we	  could	  not	  use	  this	  fixation	  device	  because	  the	  main	  goal	  of	  our	  project	  is	   to	   stimulate	   the	   re-­‐vascularization	   by	   putting	   a	   vascular	   pedicle	  inside	  the	  medullary	  canal	  of	  the	  femur,	  therefore	  a	  different	  fixation	  method	  had	  to	  be	  chosen.	  The	  first	  6	  animals,	  therefore,	  were	  used	  to	  test	  the	  surgical	  model;	  the	  remaining	  10	  were	  divided	  into	  2	  groups	  of	   5	   each.	   In	   the	   Group	   A	   the	   allograft	   was	   used	   alone	   and	   this	  represented	  the	  control	  group;	   in	  Group	  B,	   the	  artero-­‐venous	  bundle	  was	   inserted	  in	  the	  femoral	  canal	  of	   the	  allograft.	   In	  this	  preliminary	  study,	  no	  cells	  or	  growth	   factors	  were	  used;	  once	   it	   is	  demonstrated	  that	   the	   vascular	  pedicle	   insertion	   improves	   the	   revascularization	  of	  the	  allograft,	   the	  groups	  with	  MSCs	  and	  OP-­‐1	  will	  be	  performed.	  The	  chosen	  experimental	   time	  was	  6	  weeks	  as	  an	  early	   time	  point.	  Being	  the	  goal	  to	  obtain	  early	  regeneration	  and	  re-­‐vascularization,	  6	  weeks	  has	  been	  identified	  as	  the	  best	  time	  to	  evaluate	  the	  results.	  Earlier	  and	  later	  stages	  will	  have	  to	  be	  considered	  in	  the	  future.	  	  
	  
3.4	  Materials	  and	  Methods	  
	  
a)	  Surgical	  Procedure	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The	   surgical	   procedure	   is	   performed	   with	   the	   animal	   under	  general	   anaesthesia	   and	   antibiotics	   coverage.	   After	   shaving	   the	   limb	  and	   the	   groin	   area,	   the	   animal	   is	   placed	   supine	   and	   a	   longitudinal	  incision	  at	  the	  groin	  is	  performed	  in	  line	  with	  the	  inguinal	  canal.	  The	  femoral	  neurovascular	  bundle	  is	  exposed	  and	  isolated,	  and,	  following	  the	   femoral	   artery	   proximally,	   the	   superficial	   epigastric	   vessels	   are	  identified	   and	   isolated.	   These	   vessels	   are	   followed	   up	   to	   their	  proximal	   end	   through	   the	   groin	   fat,	   and,	  maintaining	   their	   perivasal	  tissue,	  are	  ligated	  after	  heparinization	  at	  the	  most	  proximal	  end	  using	  a	   nylon	   4/0,	   trying	   to	   maintain	   the	   highest	   possible	   length	   of	   this	  pedicle	   (Fig	   13).	   The	   suture	   stitch,	   at	   the	   same	   time,	   is	   kept	   long	   at	  least	   10	   cm,	   in	   order	   to	   allow	   in	   the	   second	   time	   the	   correct	  positioning	  of	  the	  pedicle	  in	  the	  femoral	  medullary	  canal.	  The	  isolated	  pedicle	   is	   temporarily	  rested	   in	  the	  wound	  and	  protected	  with	  moist	  gauze.	  	  
A	   second	   incision	   is	   performed	   as	   a	   lateral	   approach	   to	   the	  femur.	  The	  fascia	  is	  sectioned	  and	  via	  smooth	  dissection	  the	  diaphysis	  of	   the	   femur	   is	   approached	   passing	   through	   the	   vastus	   lateralis	   and	  the	   semimembranosus	   muscle.	   Using	   a	   high	   speed	   saw,	   a	   critical	  defect	  (136)	  of	  1,5	  cm	  is	  created	   in	  the	  mid-­‐shaft	  of	   the	  bone,	   taking	  care	  not	  to	  create	  any	  micro-­‐fracture	  in	  the	  very	  fragile	  cortex.	  
The	   defect	   that	   is	   created	   is	   thereafter	   filled	   with	   a	   bone	  allograft	   of	   the	   same	  dimensions	   previously	   harvested	   from	  another	  animal	  and	  stored	  in	  sterile	  conditions	  at	  -­‐80	  degrees.	  








Before	  fixing	  the	  allograft,	  a	  0.8	  drill	   is	  used	  to	  create	  a	  hole	  in	  the	   anterior	   cortex	   of	   the	  host	   bone,	   just	   proximal	   to	   the	   osteotomy	  line;	   the	   vascular	   pedicle	   previously	   harvested	   is	   heparinised	   again	  and	  then	  passed	  through	  this	  hole.	  A	  second	  hole	  is	  made	  in	  the	  distal	  part	   of	   the	   host	   bone,	   just	   distal	   to	   the	   second	   osteotomy	   line.	   The	  
Fig.	  13	  Anatomy	  view	  of	  the	  superficial	  hypogastric	  vessels	  in	  the	  
rabbit.	  Approach	  to	  the	  antero-­‐medial	  compartment	  of	  the	  
thigh,	  the	  femoral	  neuro-­‐vascular	  bundle	  is	  identified	  and	  
the	   superficial	   hypogastric	   bundle	   is	   showed	   just	  
underneath	  the	  inguinal	  fat	  pad.	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Fig.	  14	  Schematic	  picture	  of	   the	  allograft	  position	  and	   fixation.	  The	  
defect	   is	   created	   in	   the	   mid-­‐shaft	   of	   the	   rabbit’s	   femur,	   the	  
allograft	   is	   fixed	   with	   plate,	   screws	   and	   cable	   wires.	   The	  
artero-­‐venous	  bundle	  is	  inserted	  through	  a	  proximal	  hole	  into	  
the	  medullary	  canal,	  and	  fixed	  at	  its	  exit	  from	  the	  distal	  hole	  
in	  the	  cortex.	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In	  a	  second	   time,	  once	   the	  model	  will	  be	  confirmed	  as	  reliable	  and	  repeatable,	  the	  injection	  of	  MSCs	  and	  OP-­‐1	  can	  be	  done	  using	  one	  of	  the	  screw	  holes,	  using	  the	  procedure	  already	  used	  in	  our	  previous	  study	  (101).	  Once	  a	  sound	  fixation	  has	  been	  achieved,	  the	  wounds	  are	  closed	  and	  the	  X-­‐Ray	  check	  is	  performed.	  	  
One	  limit	  in	  the	  use	  of	  the	  femoral	  model	  in	  the	  rabbit	  is	  that	  it	  doesn’t	   allow	   a	   post-­‐operative	   cast	   protection,	   which	   instead	   is	  possible	   in	   the	   metatarsal	   model	   in	   the	   sheep.	   The	   cast	   provides	  stability	  and	  protects	  from	  rotational	  and	  compression	  stresses	  which	  may	  produce	  an	  early	  failure	  of	  the	  fixation.	  In	  the	  rabbits,	  being	  this	  protection	   impossible	   to	   obtain,	   the	   risk	   of	   early	   failure	   is	   therefore	  increased	  and	  needs	  to	  be	  taken	  in	  consideration.	  Together	  with	  this,	  the	   extreme	   friability	   of	   the	   cortical	   bone	  of	   the	   rabbit	   and	   the	   very	  thin	   cortex	   compared	   to	   the	  medullary	   canal	   contribute	   to	   the	   high	  risk	  of	  fixation	  instability.	  
	  
b)	  Analysis	  of	  results	  
The	   goal	   of	   this	   preliminary	   project	   is	   to	   demonstrate	   an	  improvement	  in	  bone	  allograft	  integration	  through	  an	  improvement	  of	  the	  neo-­‐vascularization	  of	  the	  graft.	  The	  analysis	  performed	  therefore	  was	   focused	   on	   the	   appearance	   of	   the	   bone,	   the	   histology	   and	   the	  viability	  and	  patency	  of	  the	  vascular	  pedicle.	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We	  aimed	  to	  evaluate	  the	  appearance	  of	  the	  implant	  using	  Xray,	  the	   viability	   and	  patency	  of	   the	   transposed	  vascular	  bundle,	   and	   the	  amount	  of	  new	  bone,	  its	  integration	  with	  the	  host,	  and	  the	  patency	  of	  the	  implanted	  vessels	  using	  histology	  and	  histomorphometry.	  
1. X-­‐Ray:	  In	  order	  to	  investigate	  the	  allograft	   integration	  all	   the	   animals	   were	   radiographed	   in	   AP	   view	  projection	   with	   a	   portable	   X-­‐ray	   machine	  (Franceschini,	  Italy)	  with	  the	  following	  program:	  70kV,	  60mA,	   0.25s.	   Hence,	   the	   images	   were	   digitised	   to	  achieve	   a	   better	   definition	   and	   evaluation.	   As	   in	   our	  previous	  works	  (101,	  110,	  119),	  we	  designed	  a	  simple	  score	   ranging	   from	  0	   to	  2	   in	   two	  different	   categories:	  osteotomy	   healing	   and	   periosteal	   callus	   presence.	   In	  the	   first	   category	   0	   was	   assigned	   when	   there	   was	  discontinuity	   in	   the	   osteotomy	   line,	   1	   for	   continuity	  but	  the	  line	  was	  still	  present,	  and	  2	  when	  the	  line	  was	  hardly	  recognizable.	  In	  the	  second	  category	  concerning	  periosteal	   callus,	   0	   equal	   to	  no	   evidence	  of	   periosteal	  callus,	   1	   to	   moderate	   presence,	   2	   to	   marked	   and	  excessive	  presence.	  2. Macroscopically	  appearance	  of	  the	  vascular	  bundle:	  At	  the	  time	  of	  harvest,	  the	  patency	  of	  the	  vascular	  bundle	  was	   analysed:	   with	   the	   animal	   in	   anaesthesia	   the	  pedicle	  was	  first	  identified	  at	  the	  proximal	  entry	  point	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and	   the	   pulse	   was	   recorded,	   then	   the	   artery	   was	  sectioned	  to	  establish	  blood	  flow	  trough	  it	  lumen.	  3. Histology	   and	   histomorphometry:	   The	   whole	   femur	  was	  explanted	  and,	  once	  freed	  from	  the	  soft	  tissue	  and	  once	  the	  plate	  was	  removed,	  fixed	  in	  Bouin	  and	  then	  in	  4%	  paraformaldehyde	  before	  being	  cut	  (Exact	  Parallel	  System,	  Hamburg,	  Germany).	  As	  reported	  before	  (101)	  the	  osteotomy	   lines	  were	   sectioned	   in	  a	   frontal	  plane	  passing	   through	   the	   polar	   line	   including	   part	   of	   the	  grafted	   bone.	   The	   remaining	   central	   part	   of	   the	  allograft	  was	  cut	  in	  a	  transverse	  plane	  (Fig	  15).	  All	  the	  specimens	   were	   embedded	   in	   methylmethacrylate	  (MMA)	  to	  achieve	  precision	  cuts	  and	  further	  grinding.	  The	   result	   was	   a	   40–70	   micron	   thickness	   slides.	  Staining	   was	   achieved	   with	   trichromic	   Masson	  technique	   (toluidin	   blu,	   acid	   fucsin,	   fast	   green).	   The	  slides	   were	   evaluated	   with	   the	   Qwin-­‐Leica	   Imaging	  System	   LTD	   (Cambridge,	   England)	   and	   digitized	   for	  histomorphometrical	  analysis.	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  The	   following	   parameters	   were	   evaluated:	   (1)	  percentage	  of	  new	  bone	  in	  the	  allograft,	  (2)	  percentage	  of	   callus	   surrounding	   the	   osteotomy	   and	   (3)	  penetration	  of	   vessel	   in	   the	   graft	   from	   the	  osteotomy	  line.	  Together	  with	   this,	   the	  patency	  of	   the	   implanted	  vessels	   was	   evaluated	   using	   Hematossilin-­‐Eosin	  staining	   in	   paraffine	   embedded	   section	   of	   the	   vessels	  at	  the	  level	  of	  the	  mid-­‐shaft	  of	  the	  allograft.	  
	  
Fig.	  15	  Schematic	  picture	  of	   the	  histology	  cuts	  performed.	  The	  most	  
central	  part	  of	   the	  allograft,	  with	   the	   vascular	  pedicle	   inside	  
it,	   is	   examined	   using	   axial	   cuts.	   The	   proximal	   and	   distal	  
osteotomy	   lines	   are	   examined	   through	   a	   sagittal	   cut	   which	  
includes	  the	  passage	  between	  the	  host	  bone	  and	  the	  allograft.	  	  	  	  




a)	  Animal	  model	  
Despite	   rabbits	   are	   simple	   animals	   to	   work	   with,	   the	   femoral	  intercalary	   defect	   presented	   several	   challenges	   that	   made	   the	  repeatability	  of	   the	  model	   a	  difficult	   goal.	  All	   the	   fixation	   techniques	  used	  showed	  difficulty	  on	  the	  achievement	  of	  fixation	  stability,	  mainly	  due	  to	  the	  brittle	  characteristics	  of	  the	  rabbit	  bone.	  
-­‐ Plate	  and	  screws,	  no	  cables.	  2	  animals	  The	   first	   attempt	  was	   done	   following	   the	   protocol	   of	   the	  well	  established	  metatarsal	  model	   in	   the	   sheep.	   A	   8	   holes	   LCP	   plate	  was	  chosen	   and	   fixed	   to	   the	   bone	   with	   bi-­‐cortical	   screws,	   however	   the	  fragility	   of	   the	   bone	   in	   both	   the	   allograft	   and	   the	   host	   site	   did	   not	  allow	   a	   stable	   and	   sound	   fixation.	   The	  bone,	   in	   fact,	   tended	   to	   crack	  with	   the	   drill	   and,	   even	   more,	   with	   the	   compression	   of	   the	   screws,	  despite	  a	  good	  position	  of	  them.	  In	  both	  the	  animals	  a	  fracture	  in	  the	  proximal	  and	  distal	  femur	  was	  evident	  at	  day	  1	  post	  op,	  therefore	  the	  animals	  had	  to	  be	  sacrificed.	  	  	  -­‐ Plate,	  screws	  and	  metallic	  cables.	  4	  animals	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The	   following	   4	   animals	   received	   fixation	   with	   a	   6	   holes	   LCP	  plate,	   2.7	  mm	   (small	   fragment)	   screws	   (2	   in	   the	  proximal	  host	  bone	  and	  2	   in	   the	  distal)	   associated	  with	  0.8	   Charnely	  wires	   used	   around	  the	  plate	  and	  the	  allograft	  as	  further	  stabilizer.	  This	  choice	  was	  made	  in	  order	  to	  avoid	  excessive	  drilling	  of	  the	  allograft,	  therefore	  avoiding	  possible	  fracture	  propagation.	  With	  this	  method,	  a	  better	  fixation	  was	  achieved.	  	  Despite	   the	   good	   post-­‐operative	   result,	   loss	   of	   fixation	   was	  noted	  at	   the	  allograft-­‐host	   junction	  respectively	  after	  5,	  7,	  14	  and	  17	  days	   post-­‐op,	   suggesting	   that	   the	   metallic	   cables	   did	   not	   confer	  enough	  stability	  to	  the	  construct	  and	  that	  the	  fixation	  at	  the	  level	  f	  the	  host	  bone	  was	  not	  achieved	  with	  the	  use	  of	  only	  2	  screws	  (Fig	  16).	  	  The	   difficulty	   in	   the	   use	   of	   the	   metallic	   wires	   was	   noted	  especially	   in	   their	   tightening,	   as	   an	   excessive	   force	   would	   have	  resulted	  in	  the	  fracture	  of	  the	  graft	  or	  the	  host	  cortical	  bone.	  This,	   in	  fact,	  happened	  in	  one	  animal.	  On	  the	  contrary,	  when	  the	  wire	  was	  left	  not	  excessively	  tightened,	  the	  loss	  of	  fixation	  was	  the	  result	  after	  few	  days.	   The	   fact	   that	   the	   animal	   was	   free	   to	   weight	   bear	   in	   the	  immediate	   post-­‐operative	   period	   led	   to	   excessive	   rotational	   stresses	  at	  the	  femur,	  with	  increased	  chances	  of	  early	  failure.	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  -­‐	  Plate,	  screws	  and	  plastic	  cables.	  10	  animals	  
After	   the	   failure	  with	  metallic	  wires,	  we	   improved	  our	   fixation	  using	   plastic	   self-­‐locking	   cables	   associated	   with	   a	   longer	   plate	   (8	  holes).	  The	  cables	  allowed	  a	  good	  primary	  stability	  and	  decreased	  the	  risk	   of	   over-­‐tightening	   and	   iatrogenic	   fracture.	   The	   difficulty	  
	  
Fig.	  16	  Xray	  of	  the	  femoral	  allograft	  fixed	  with	  6	  holes	  DCP	  plate,	  screws	  and	  
metallic	   cable	   wires.	   A)	   Post	   operative	   check,	   with	   satisfactory	  
position	  of	  the	  allograft	  and	  apparent	  satisfactory	  fixation.	  B)	  1	  week	  
post-­‐operative	  Xray	  check,	  loss	  of	  fixation	  at	  the	  proximal	  osteotomy.	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Fig.	  17	  Xray	  of	  the	  femoral	  allograft	  fixed	  with	  8	  holes	  DCP	  plate,	  screws	  and	  
plastic	  cable	  wires.	  A)	  Post	  operative	  check,	  with	  satisfactory	  position	  
of	  the	  allograft	  and	  apparent	  satisfactory	  fixation.	  Note	  the	  3	  screws	  
(6	   cortices)	   fixation	  both	  proximal	  and	  distal	   in	   the	  host	  bone.	  B)	  6	  
week	   post-­‐operative	   Xray	   (femur	   harvested	   at	   the	   end	   of	   the	  
experimental	   time),	   good	   fixation	   maintained	   at	   the	   proximal	   and	  
distal	   osteotomies.	   Note	   in	   transparency	   the	   shape	   of	   the	   plastic	  
cable.	  Note	  the	  big	  amount	  of	  callus	  around	  the	  screws	  and	  the	  lack	  
of	  healing	  at	  the	  osteotomy	  sites.	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b)	  Clinical	  Complications	  
Despite	  a	  good	  and	  satisfactory	  intra-­‐operative	  allograft	  fixation	  in	   the	   animals	   treated	  with	   8	   holes	   plate,	   screws	   and	   plastic	   cables,	  some	  complication	  still	  occurred.	  There	  were	  2	  infections	  (1	  in	  Group	  A	  and	  1	  in	  Group	  B),	  and	  3	  late	  fractures	  (2	  in	  Group	  A,	  1	  in	  group	  B).	  These	  animals	  had	  to	  be	  sacrificed	  before	  the	  end	  of	  the	  experimental	  time	   and	   therefore	   were	   not	   evaluated.	   As	   a	   consequence,	   these	  complications	  led	  to	  a	  small	  number	  of	  animals	  available	  for	  analysis.	  
The	  remaining	  animals	  available	  for	  evaluation	  were:	  2	  group	  A	  and	  3	  group	  B.	  Because	  of	  the	  poor	  clinical	  outcome	  and	  the	  difficulty	  on	  the	  repeatability	  of	  the	  surgical	  procedure,	   for	  ethical	  reasons	  the	  model	  had	  to	  be	  abandoned	  and	  no	  further	  attempts	  were	  performed,	  with	   a	   following	   plan	   of	   moving	   to	   a	   larger	   animal	   model	   (sheep)	  already	  well	  consolidated.	  
	  
c)	  Macroscopic	  evaluation	  
When	   no	   complications	   occurred	   during	   the	   6	   weeks	   of	   the	  experimental	  time,	  the	  femur	  was	  dissected	  free	  form	  the	  surrounding	  soft	  tissue,	  disarticulated	  at	  the	  hip	  and	  knee	  levels,	  and	  harvested	  for	  analysis.	   At	   the	   time	   of	   harvest,	   despite	   the	   good	   position	   of	   the	  allograft	  and	  the	  absence	  of	  clinical	  infection,	  in	  all	  animals	  regardless	  of	  the	  group,	  an	  important	  amount	  of	  macroscopically	  reactive	  tissue	  was	   evident	   in	   the	   area	   of	   the	   plastic	   cables.	   An	   abundant	   and	  
	   64	  






Fig.	  18	  Macroscopic	  appearance	  of	  the	  femur	  after	  its	  harvest.	  The	  allograft	  
is	   maintained	   in	   acceptable	   position	   by	   the	   plastic	   cables,	   but	   no	  
integration	   is	   seen	   at	   the	   osteotomy	   lines.	   Big	   callus/soft	   tissue	  
formation	  is	  noted	  at	  the	  proximal	  ond	  distal	  host	  bone.	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d)	  Transplanted	  vessel	  evaluation	  
At	   the	   time	   of	   harvest,	   before	   the	  whole	   femur	  was	   retrieved,	  the	  patency	  of	   the	  vascular	  bundle	  was	  analysed:	  with	   the	  animal	   in	  anaesthesia	  the	  pedicle	  was	  first	  identified	  at	  the	  proximal	  entry	  point	  and	  the	  pulse	  was	  recorded,	  then	  the	  artery	  was	  sectioned	  to	  establish	  blood	  flow	  trough	  its	  lumen.	  	  	  
In	  2	  of	  the	  cases	  belonging	  to	  Group	  B	  the	  pedicle	  was	  shown	  to	  be	  not	  pulsatile,	  and	  after	  the	  vessels	  section	  no	  blood	  flow	  has	  been	  shown.	  The	  lumen	  was	  thrombotic	  at	  the	  proximal	  level	  of	  the	  pedicle	  starting	   from	  the	  emergency	  of	   the	  branch	   from	  the	   femoral	  vessels.	  No	  clear	  torsional	  movement	  at	  the	  level	  of	  the	  superficial	  hypogastric	  vessels	  emergency	  was	  evident,	  but	  the	  thrombotic	  process	  was	  noted	  starting	  at	   the	  emergency	  of	   the	  branch.	   	   It	  was	  clear,	   therefore,	   that	  the	  allograft	  did	  not	   receive	  any	  blood	  supply.	   In	  one	  case,	  however,	  the	   vascular	   bundle	   showed	   to	   be	   patent	   with	   good	   flow	   after	   its	  section.	  
Despite	  the	  vessels	  occlusion	  in	  2	  out	  of	  3	  cases,	  the	  subsequent	  imaging	  examinations	  were	  still	  performed	  because	  no	  clear	  timing	  on	  the	   thrombotic	   process	   was	   known,	   and	   therefore	   some	   early	  vascularization	  could	  have	  still	  happened.	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Fig.	   19	   Xray	   results	   for	   control	   and	   study	   groups.	   There	   was	   no	   relevant	  
difference	  between	   the	   two	  groups	   in	   terms	  of	   callus	   formation	  nor	  
healing	  at	  the	  osteotomy	  lines.	  	  
d)	  Imaging	  	  
The	  rabbits	  were	  evaluated	  radiographically	  and	  histologically.	  The	  small	  number	  of	  sample	  did	  not	  allow	  any	  statistical	  analysis.	  On	  X-­‐Ray	   exam,	   no	   difference	   was	   evident	   between	   the	   two	   groups	   of	  animals	  with	  regards	  of	  callus	  formation	  or	  bone/allograft	  integration.	  In	   both	   groups,	   an	   abundant	   callus	   was	   noted	   starting	   from	   the	  proximal	  host	  bone,	   just	  proximal	   to	   the	   first	   screw,	  which	   indicates	  an	  attempt	  of	  fixation	  via	  external	  bone	  bridging	  (Fig:	  RIV	  15	  and	  16..	  will	  be	  group	  A	  and	  B).	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0 0 1 0   
Group B (Pedicle) 
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Fig.	  20	  Histology	  of	  a	   longitudinal	   cut	  at	   the	   level	   of	   the	  osteotomy	  
line	   in	  Gourp	  A	   (Control).	   Abundant	   callus	   is	  noted.	  The	   gap	  
between	   the	   host	   and	   the	   graft	   bone	   is	   still	   present	  with	   no	  
evidence	   of	   allograft	   remodelling.	   1,25	   x,	   Metacrilate	  
embedding,	  Masson	  Trichromic	  staining.	  
e)	  Histology	  	  
The	  histology	  has	  been	  performed	  in	  the	  available	  animals.	  The	  amount	   of	   bone	   formation	   in	   the	   allograft	   and	   the	   quality	   of	  consolidation	  has	  been	  studied.	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In	  group	  A	  the	  histology	  showed	  an	  abundant	  callus	   formation	  around	   the	   proximal	   and	   the	   distal	   osteotomy	   line.	   The	   callus	   was	  formed	  by	  woven	  immature	  bone	  with	  a	  component	  of	  fibrous	  tissue.	  The	  allograft	  in	  all	  cases	  showed	  no	  new	  bone	  formation	  and	  did	  not	  show	  signs	  of	   remodelling;	   at	   the	   level	   of	   the	  osteotomy	   sites,	   a	   gap	  between	  the	  host	  and	  the	  graft	  was	  present	  with	  minor	  fibrous	  tissue.	  (Fig	  20)	  There	  was	  no	  evidence	  of	  revascularization	  process.	  
In	  Group	  B	   the	   patency	   of	   the	   artero-­‐venous	   pedicle	   has	   been	  shown	   to	   be	   deficient	   in	   2	   out	   of	   3	   animals.	   In	   those	   2	   animals	   the	  histology	   picture	   was	   comparable	   to	   the	   ones	   seen	   in	   the	   control	  group,	  with	  no	  evidence	  of	  allograft	   remodelling.	   In	   the	  animal	  were	  the	  pedicle	  was	  patent,	  there	  was	  evidence	  of	  new	  bone	  formation	  in	  the	  medullary	  canal	  with	  some	  endosteal	  bone	  remodelling	   (Fig	  21),	  and	  this	  was	  evident	  both	  at	  the	  level	  of	  the	  osteotomy	  lines	  and	  at	  the	  more	  central	  part	  of	  the	  allograft	  (Fig	  23).	  
	  With	   regards	   to	   the	  vascular	  pedicle,	   in	   the	   cases	  were	   it	  was	  macroscopically	  not	  pulsatile	  the	  histology	  showed	  an	  occluded	  artery	  with	  a	   full	   thickness	   thrombus.	  The	  vein,	  on	   the	  other	  hand,	   showed	  patency	   but	   no	   evidence	   of	   blood	   in	   its	   lumen.	   In	   the	   only	   case	   in	  which	   the	   pedicle	   showed	   to	   be	   pulsatile,	   histology	   confirmed	   the	  patency	  of	  the	  artery	  with	  no	  thrombotic	  process.	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Fig.	  21	  Histology	  of	  a	  transverse	  cut	  in	  the	  allograft	  in	  Group	  B	  with	  
patent	   vascular	  bundle.	  Endosteal	  bone	   remodelling	   is	  noted	  
with	   new	   bone	   formation	   and	   new	   vessel	   formation.	   1,25	   x,	  
Metacrilate	  embedding,	  Masson	  Trichromic	  staining.	  	  
Fig.	  22	  Histology	  of	  vessels;	  the	  
artery	   spears	   occluded	   by	  
a	   full	   thickness	   thrombus,	  
while	   the	   vein	   is	   patent.	  
Magnification	   2	   x,	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Fig.	   23	   Table	   representing	   the	   amount	   of	   new	   bone	   at	   the	   level	   of	   the	  
osteotomy	   lines	   in	   the	   longitudinal	   cuts,	   and	   at	   the	   level	   of	   the	  
central	  part	  of	  the	  graft	  in	  the	  axial	  cuts.	  The	  values	  are	  expressed	  
as	  a	  percentage	  of	  the	  total	  allograft	  bone	  in	  the	  histology	  slice.	  In	  
the	   animal	   with	   the	   patent	   pedicle	   (Study	   3)	   there	   was	  
substantial	   more	   new	   bone	   in	   both	   areas	   compared	   to	   all	   the	  
other	  samples.	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3.6	  Discussion	  
The	   concept	   of	   scaffold	   re-­‐vascularization	   to	   promote	   its	  integration	   into	   a	   tissue	   and	   its	   revitalization	  has	   been	   known	   since	  many	   years.	   Vessel	   re-­‐implantation	   into	   avascular	   bone	   is	   already	   a	  very	   well	   known	   clinical	   strategy	   in	   the	   treatment	   of	   bone	  osteonecrosis	   such	   as	  Kienbock	   disease	   (137)	   or	   scaphoid	   avascular	  necrosis	   (138,	  139).	  More	  recently,	   some	  studies	  have	  been	   focusing	  their	  attention	  on	  the	  possibility	  to	  introduce	  a	  vascular	  pedicle	  into	  a	  bone	  allograft	   to	   stimulate	   its	   remodelling	   and,	   by	   adding	   stem	  cells	  and/or	   growth	   factors,	   to	   further	   improve	   the	   new	   bone	   formation	  (120,	   123,	   140).	   These	   studies	   showed	   that	   the	   implantation	   of	   a	  vascular	  pedicle	  into	  a	  stem	  cells	  seeded	  scaffold	  noticeably	  improves	  neo-­‐vascularization	   and	  osteocytic	   repopulation	  of	   previously	   a-­‐vital	  bone	   allograft.	   These	   results	   have	   been	   obtained	   in	   a	   not	   loaded	  condition,	   such	   as	   the	   subcutaneous	   pouch	   of	   the	   animal.	   The	  outcomes	   of	   these	   studies	   are	   very	   encouraging,	   and	   therefore	   the	  application	  of	  this	  technique	  for	  the	  revascularization	  of	  the	  allograft	  in	  a	  loaded	  condition	  would	  add	  substantial	  benefit.	  The	  main	  reason	  for	   this	   is	   the	   possibility	   of	   immediate	   clinical	   application,	   while	  obtaining	   a	   remodelled	   bone	   in	   a	   subcutaneous	   pouch	   remains	  ethically	  controversial	  and	  clinically	  more	  difficult	  to	  perform.	  
A	   good	   animal	   model	   is	   of	   paramount	   importance	   to	   obtain	  reliable	   results	   in	   an	   in-­‐vivo	   experimental	   protocol.	   Following	   our	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experience	  with	   the	  sheep,	   the	   rabbit	   femoral	  model	   seemed	   to	  be	  a	  very	  good	  small	  animal	  model	  to	  start	  our	  project.	  The	  concept	  of	  our	  reconstruction	  did	  not	  allow	  us	  to	  perform	  the	  fixation	  method	  that	  is	  most	   common	   in	   literature	   (141,	   142),	  which	   involves	   the	   use	   of	   an	  intramedullary	   pin.	   This	   has	   been	   considered	   a	   reliable	   and	  reproducible	   technique,	   however	   the	   insertion	   of	   an	   artero-­‐venous	  pedicle	   inside	   the	   femoral	  medullary	   canal	  made	   this	   procedure	   not	  possible.	   Therefore,	   we	   had	   to	   use	   the	   plate	   and	   screws	   internal	  fixation	  technique,	  which	  is	  the	  same	  that	  we	  used	  in	  the	  large	  animal	  model	  and	  is	  the	  same	  that	  would	  be	  used	  in	  humans.	  Unfortunately,	  the	   characteristics	   of	   the	   rabbit	   bone,	   its	   friability	   and	   the	   reduced	  ratio	  of	  cortex	  thickness/medullary	  canal	  diameter	  at	  the	  level	  of	  the	  femoral	   diaphysis	   made	   the	   procedure	   technically	   very	   challenging.	  Together	  with	   the	   difficulty	   of	   the	   procedure,	   the	   high	   rate	   of	   intra-­‐operative	   and	   post-­‐operative	   complications	   has	   been	   shown.	   A	  consideration	  that	  has	  to	  be	  made	  in	  this	  contest	  is	  the	  impossibility	  to	  obtain	  a	  post-­‐operative	  protection	  bandage	  or	  cast	  in	  the	  rabbit	  femur,	  which	  evolves	  in	  the	  animal	  free	  to	  move	  after	  surgery.	  In	  the	  sheep,	  in	  fact,	  when	  an	  intercalary	  defect	  is	  performed	  in	  the	  metatarsal	  bone,	  a	  post-­‐operative	   cast	   is	   performed	   and	   maintained	   for	   4	   weeks.	   This	  represents	   the	   standard	   post-­‐operative	   protocol	   after	   any	   allograft	  procedure,	  because	  allow	  enough	  protection	  from	  weight	  bearing	  and,	  most	  of	  all,	  from	  all	  rotational	  and	  torsional	  stresses	  at	  the	  level	  of	  the	  osteotomies.	   The	   impossibility	   of	   performing	   this	   procedure	   in	   the	  rabbit	  increased	  considerably	  the	  risk	  of	  failure.	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With	  the	  final	  modification	  of	  the	  technique,	  a	  satisfactory	  intra-­‐operative	   fixation	   has	   been	   achieved,	   with	   good	   stability	   of	   the	  allograft	   and	   a	   lower	   fracture	   rate.	   With	   this	   technique,	   however,	  despite	   a	   relatively	   stable	   post-­‐operative	   stability,	   some	   late	  complications	   (infection	   and	   late	   fracture)	  occurred	  and	   jeopardized	  the	  final	  outcome.	  In	  these	  circumstances,	  only	  5	  overall	  animals	  were	  available	  for	  analysis,	  with	  understandably	  no	  room	  for	  any	  statistical	  consideration.	  	  
Another	  extremely	  important	  point	  to	  consider	  is	  the	  patency	  of	  the	   vascular	   bundle	   inserted	   into	   the	   medullary	   canal.	   In	   this	   first	  project,	   no	   cells	   nor	   growth	   factors	  were	   added	   to	   the	   allograft,	   and	  the	   main	   study	   was	   focused	   on	   the	   implementation	   of	   the	   allograft	  incorporation	   by	   the	   addition	   of	   the	   vessel.	   This	   is	   a	   necessary	   step	  before	  moving	  to	  the	   introduction	  of	  more	  complexes	  procedure	  and	  in	   vitro	   processes	   to	   obtain	   autologous	   stem	   cells.	   From	   the	  macroscopically	  point	  of	  view,	  at	  the	  harvest	  time	  it	  was	  evident	  that	  the	  vascular	  bundle	  was	  not	  patent	  in	  two	  out	  of	  three	  cases.	  As	  well	  as	  macroscopically	   findings,	   histology	   results	   from	   Group	   B	   showed	  that	   the	   vessels	   had	   a	   full	   thickness	   thrombosis,	   which	   didn’t	   allow	  any	   revascularization	   of	   the	   allograft.	   There	   are	   many	   reasons	   that	  could	  explain	   the	  occurrence	  of	   the	   thrombosis.	  The	  extremely	  small	  dimension	  of	  the	  vascular	  pedicle	  has	  to	  be	  taken	  into	  account	  in	  first	  instance;	   moreover,	   despite	   the	   heparinization	   of	   the	   vessels,	   their	  rotation	   around	   the	  major	   vessels	   trunk	   is	   one	   of	   the	  main	   possible	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reasons	   for	   the	   occlusion.	   In	   one	   case	   there	   was	   no	   thrombosis	  evident,	   and	   therefore	   it	   is	   possible	   to	   transfer	   the	   pedicle	   avoiding	  the	   occlusion	   of	   the	   vessels	   as	   long	   as	   high	   care	   is	   taken	   to	   avoid	  excessive	   torsion	   of	   the	   pedicle.	   The	   choice	   of	   leaving	   as	   much	   fat	  tissue	   around	   the	   pedicle	   as	   possible	   has	   been	   made	   to	   avoid	  thrombosis	  as	  well.	  The	  soft	  tissues,	   in	   fact,	  protect	  the	  small	  vessels	  from	  excessive	  surgical	   traumatization	  and,	  at	   the	  same	  time,	  should	  allow	  and	  encourage	  the	  formation	  of	  artero-­‐venous	  anastomosis.	  To	  improve	   the	   outcome	   of	   the	   pedicle	   patency,	   an	   artero-­‐venous	  anastomosis	  can	  be	  created	  at	  the	  end	  of	  the	  loop;	  this	  would	  improve	  the	  blood	  flow	  and,	  moreover,	  would	  give	  the	  chance	  to	  check	  the	  flow	  intra-­‐operatively.	  
Histologically	   there	  was	   no	   difference	   in	   the	   graft	   appearance	  between	   the	   two	   groups,	   indicating	   that	   the	   thrombosis	  most	   likely	  occurred	   at	   an	   early	   stage,	   avoiding	   any	   blood	   supply.	   In	   the	   only	  animal	   in	   which	   a	   satisfactory	   patency	   has	   been	   seen,	   different	  histological	   results	   were	   evident,	   mainly	   in	   terms	   of	   endosteal	   new	  bone	  formation.	  This	  is	  encouranging	  for	  future	  studies,	  as	  it	  indicates	  that	   improvement	   in	   the	   intra-­‐medullary	   vascularization	   in	   loaded	  massive	   allograft	  might	   result	   in	  higher	   endosteal	  bone	   remodelling,	  leading	  to	  a	  better	  allograft	  regeneration	  and	  incorporation.	  One	  case	  however	  cannot	  prove	  this	  concept,	  and	  further	  studies	  are	  necessary	  to	  assess	  this.	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Future	   studies	   are	   necessary	   mainly	   to	   improve	   the	   animal	  model.	  The	  small	  animal	  has	  demonstrated	  to	  be	  not	  the	  best	  model	  to	  test	   the	   intra-­‐medullary	   artero-­‐venous	   implantation	   for	   the	  improvement	  of	  the	  integration	  and	  regeneration	  of	  a	  cortical	  massive	  bone	   allograft,	   because	   fixation	   techniques	   do	   not	   allow	   a	   good	  stability.	   At	   the	   same	   time,	   the	   extremely	   small	   dimensions	   of	   the	  vessels	  require	  microsurgical	  techniques	  to	  perform	  an	  artero-­‐venous	  anastomosis,	   with	   still	   very	   high	   chances	   of	   vessel	   thrombosis.	  	  Together	  with	  this,	  the	  impossibility	  to	  perform	  a	  post-­‐operative	  cast	  to	   protect	   the	   construct	   further	   increases	   the	   risk	   of	   complications.	  The	   sheep	  model,	   on	   the	   other	   hand,	   has	   been	   proven	   to	   be	   a	   very	  reliable	  and	  efficient	  model	  for	  intercalary	  bone	  graft	  studies,	  and	  we	  believe	  that	  this	  model	  will	  be	  the	  one	  that	  will	  give	  an	  answer	  wether	  a	   vascular	   bundle	   can	   change	   the	   natural	   history	   of	   allograft	  integration.	   The	  metatarsal	   sheep	  model	   not	   only	   allow	   a	   good	   and	  stable	  fixation	  with	  plate	  and	  screws,	  but	  there	  is	  the	  possibility	  in	  the	  post-­‐operative	   time,	   to	  perform	  a	  cast	  and	  avoid	   the	  weight-­‐bearing,	  so	   to	   improve	   the	   chances	   of	   allograft	   integration,	   exactly	   as	   it	  happens	   in	   humans.	   Unfortunately	   there	   are	   limits	   with	   this	   large	  animal	  model:	  it	  doesn’t	  allow	  big	  number	  of	  experimental	  procedures	  and	  it	   is	  very	  costly;	  moreover,	  an	  animal	  facility	  with	  the	  possibility	  of	  working	  with	  large	  animals	  is	  necessary.	  These,	  however,	  are	  limits	  that	  can	  be	  overtaken	  by	  working	  in	  a	  high	  level	  experimental	  facility.	  The	  future	  plan,	  therefore,	  is	  to	  translate	  this	  experiment	  to	  the	  sheep	  model.	   	  
	   76	  
	  
4.	  SOFT	  TISSUE	  REGENERATION	  PROJECT	  
	  
	  
4.1	  Background	  	  
	  
While	   patients	   with	   ESTS	   were	   historically	   treated	   by	  amputation	   (143),	   current	   multimodal	   approaches	   combining	   wide	  surgical	   resection	   with	   (neo)adjuvant	   radiotherapy	   and/or	  chemotherapy	  allow	  limb	  preservation	  in	  90–95%	  of	  patients,	  without	  compromising	   disease	   recurrence	   and	   survival	   (144-­‐148).	   However,	  managing	   tumors	   with	   a	   limb-­‐salvage	   approach	   can	   create	   complex	  soft	   tissue	   defects	   susceptible	   to	   wound	   healing	   difficulties	   in	   the	  postoperative	  period	   (105,	   149).	  Reconstructive	   surgery	   in	   the	   form	  of	   pedicled	   and	   free	   tissue	   transfers	   has	   become	   paramount	   to	   the	  success	  of	   limb	  preservation	   in	   these	  difficult	   cases.	   Indeed,	   surgical	  flaps	   help	   to	   attain	   wound	   closure,	   fill	   surgical	   dead	   space,	   protect	  critical	   structures	   (i.e.,	   nerves,	   tendons,	   joints),	   and	   promote	  wound	  healing	  (105,	  149-­‐152).	  	  A	   very	   recent	   study	   (153)	   examined	   the	   function	   and	   health	  status	   outcomes	   following	   soft	   tissue	   reconstruction	   for	   limb	  preservation	  in	  extremity	  soft	  tissue	  sarcoma.	  The	  primary	  objectives	  of	   this	   study	  were:	   1)	   to	   compare	  postoperative	   function	   and	  health	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status	   in	   Extremity	   Soft	   Tissue	   Sarcoma	   (ESTS)	   patients	   undergoing	  limb	   salvage	   with	   and	   without	   soft	   tissue	   reconstruction,	   and	   2)	   to	  examine	  the	  effect	  of	  surgical	  flaps	  on	  function	  and	  health	  status	  at	  1–2-­‐year	   follow-­‐up.	   Additionally,	   this	   study	   examined	   the	   relationship	  between	  soft	  tissue	  reconstruction	  and	  postoperative	  complications	  in	  ESTS	   patients	   undergoing	   limb-­‐preserving	   surgery.	   This	   study	   has	  demonstrated	   that	   patients	   who	   received	   a	   flap	   reconstruction	   had	  significantly	  more	   impairments	   and	   activity	   limitations	   at	   1–2	   years	  postoperatively	  than	  patients	  in	  the	  primary	  closure	  group.	  	  A	   number	   of	   factors	   may	   contribute	   to	   this	   finding.	   Patients	  receiving	  flaps	  had	  significantly	   larger	  and	  higher-­‐grade	  tumors	  than	  patients	   treated	  with	  primary	   closure,	   and	  were	  more	   likely	   to	  have	  received	   preoperative	   irradiation,	   bone	   resection,	   and	   motor	   nerve	  resection.	   Each	   of	   these	   tumor	   and	   treatment	   factors	   has	   been	  associated	  with	  worse	   function	   and/or	   health	   status	   outcomes	   in	   at	  least	   one	   prior	   study	   of	   ESTS	   patients	   undergoing	   limb-­‐salvage	  surgery	   (154-­‐157).	   Moreover,	   patients	   in	   the	   reconstruction	   group	  had	   more	   preoperative	   activity	   limitations.	   In	   addition	   to	   that,	  patients	   receiving	   flap	   reconstruction	   had	   more	   complications	   than	  patients	  treated	  with	  primary	  closure	  in	  this	  study	  (41%	  of	  56	  versus	  31%	  of	  191),	  although	  this	  difference	  was	  not	  statistically	  significant.	  Together	   with	   this,	   having	   a	   non-­‐innervated	   flap	   may	   affect	   the	  activity	   limitations	   and	   negatively	   influence	   the	   overall	   outcome.	  	  Despite	  all	  these	  findings,	  interestingly	  postoperative	  MSTS	  and	  TESS	  scores	   in	   patients	   requiring	   extremity	   reconstruction	   were	   not	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substantially	   worse	   compared	   to	   patients	   who	   received	   primary	  closure.	   Also	   interesting	   is	   the	   fact	   that	   patients	   requiring	  reconstructive	  surgery	  in	  this	  study	  reported	  similar	  participation	  and	  health	  status	  outcomes	  to	  patients	  treated	  with	  primary	  closure.	  This	  findings	  suggests	  that	  patients	  with	  reconstructed	  extremities	  are	  able	  to	   maintain	   similar	   social	   and	   occupational	   functioning	   and	   overall	  well-­‐being	   compared	   with	   patients	   not	   requiring	   reconstructive	  surgery,	   despite	   greater	   restrictions	   in	   the	   physical	   and	   activity	  domains	  of	  function.	  From	   our	   prospective,	   hence,	   patients	   who	   require	  reconstructive	   surgery	   for	   limb	   preservation	   can	   achieve	   good	  functional	   outcomes.	   It	   seems	   important,	   therefore,	   that	  when	  a	   flap	  reconstruction	   is	   necessary	   in	   order	   to	   guarantee	   limb	   sparing	  surgery,	   the	   functional	  outcome	  after	  plastic	   reconstruction	  could	  be	  improved	  as	  much	  as	  possible,	  so	  to	  give	  the	  best	  possible	  chances	  to	  these	  patients	  to	  return	  to	  their	  previous	  activities.	  In	   addition	   to	   these	   considerations,	   the	   role	   of	   radiotherapy	  needs	   to	   be	   taken	   into	   account.	   In	   the	   mid-­‐1970s	   the	   rate	   of	  amputation	   for	   extremity	   soft	   tissue	   sarcomas	   was	   40–50%	   (158,	  159).	   Radiation	   therapy	   was	   not	   considered	   to	   be	   a	   potentially	  curative	  modality	   for	   the	   large	   tumor	  masses	   although	   palliation	   of	  symptoms	   would	   often	   be	   obtained.	   In	   mid	   1980s,	   however,	  Rosenberg	   and	   colleagues	   reported	   that	   when	   compared	   with	  amputation,	  wide	  excision	  with	  external	  beam	  radiation	  therapy	  was	  associated	   with	   equivalent	   5-­‐year	   disease-­‐free	   and	   overall	   survival	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(160).	  The	  combination	  of	  surgery	  and	  radiotherapy	  has	  been	  proven	  to	  yields	  superior	   local	   control	   compared	   to	   local	  excision	  alone	  and	  has	  been	  fundamental	  to	  the	  adoption	  of	  limb-­‐conserving	  therapy	  for	  high-­‐risk	  extremity	  STS	  (145,	  161-­‐163).	  Preoperative	  RT	  is	  preferred	  at	  our	  Institute	  (St	  Vincent’s	  Hospital,	  Melbourne)	  because	  of	  smaller	  RT	  targets	  (164,	  165),	  lower	  RT	  dose	  due	  to	  better	  limb	  perfusion	  and	  oxygenation	   (166)	   and	   decreased	   late	   toxicity	   (167)	   compared	  with	  postoperative	  RT	  despite	  a	  slight	  higher	  rate	  of	  wound	  complications.	  
The	  role	  of	  free	  or	  pedicled	  flaps	  becomes	  extremely	  important	  after	   pre-­‐operative	   radiotherapy,	   because	   the	   damages	   that	   the	  radiations	   procure	   to	   the	   surround	   skin	   do	   not	   allow	   a	   riskless	  primary	  closure	  (168).	  The	  use	  of	  re-­‐innervated	  flaps	  has	  proven	  to	  be	  invaluable	   in	   numerous	   reconstructive	   procedures	   for	   example	   in	  brachial	   plexus	   injuries	   and	   Volkmann's	   contracture	   or	   for	   elbow	  reconstructions	  (169),	  and	  more	  recently	  their	  use	  has	  been	  proposed	  in	  soft	  tissue	  sarcomas	  (70,	  170-­‐172).	  
Re-­‐innervated	   muscle	   transfer	   can	   provide	   active	   contraction	  and	  soft	  tissue	  coverage,	  and	  therefore	  seems	  to	  be	  extremely	  suitable	  for	   reconstructions	   after	   soft	   tissue	   sarcomas	   resection.	   To	   our	  knowledge	  this	  is	  the	  first	  study	  that	  evaluates	  the	  functional	  outcome	  of	  innervated	  muscle	  transfer	  in	  the	  setting	  of	  irradiated	  limbs	  for	  soft	  tissue	  sarcomas	  in	  multiple	  locations	  and	  using	  multiple	  type	  of	  flaps.	  
	  4.2 Patients	  and	  Methods	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From	   2006	   to	   2010,	   14	   patients	   have	   been	   treated	   with	   neo-­‐adjuvant	  radiotherapy	  and	  resection	  for	  soft	  tissue	  sarcoma	  followed	  by	  reconstruction	  with	  innervated	  flap.	  The	  demographic	  is	  showed	  in	  table	  1.	  The	  resection	  and	  the	  flap	  reconstruction	  were	  performed	  in	  one	   stage	   for	   all	   the	   patients.	   	   There	   were	   4	   malignant	  fibrohistiocitoma,	  4	  pleyomorphic	  soft	  tissue	  sarcoma,	  3	  liposarcoma,	  1	   neurofibrosarcoma,	   1	   DFSP	   and	   1	   metastatic	   chondroblastic	  osteosarcoma	  with	  abundant	  soft	  tissue	  extension.	  	  
All	  the	  patients	  received	  pre-­‐operative	  radiotherapy	  (range	  50-­‐60	  Gy)	  and	  one	  received	  pre-­‐operative	  chemotherapy	  associated.	  
The	  resection	  was	  wide	  in	  all	  the	  cases	  except	  in	  one,	   in	  which	  the	  margins	   were	  marginal	   due	   to	   pathologic	   fracture	   in	  metastatic	  chondroblastic	   osteosarcoma	   of	   the	   femoral	   shaft	   with	   extension	   in	  the	  soft	  tissues.	  
The	   resection	   involved	   the	   lower	   limb	   in	   11	   patients	   and	   the	  upper	  limb	  in	  3.	  In	  the	  lower	  leg,	  the	  resection	  involved	  the	  posterior	  compartment	  in	  2	  patients	  (gastrocnemius	  and	  soleus	  in	  one	  patient;	  flexor	  digitorum	  longus,	  flexor	  hallucis	  longus	  and	  soleus	  in	  the	  other	  patient)	  including	  the	  tibialis	  nerve	  in	  both	  cases;	  in	  the	  other	  one	  the	  resection	  involved	  the	  anterior	  compartment	  and	  the	  muscle	  replaced	  was	  the	  tibialis	  anterior.	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Tab.	   1	   Patients	   dempgraphics,	   tumor	   histology,	   compartment	   involved,	  
dimensions	  of	  the	  resection,	  margins	  achieved	  and	  adjuvant	  therapy	  	  	   	  
Pt	   Age	   Histology	   Localization	   Tumor	  
Dimensions	  
(mm)	  
Margins	   Adjuvant	  
Therapy	  
1	   40	   Dermatofibrosarcoma	  protuberans	   lower	  leg,	  post	  compartment	   100	  x	  55	  x	  50	   wide	   RT	  pre-­‐op	  2	   68	   MFH	  (recurrent)	   Left	  buttock	   260	  x	  160	  x	  70	   wide	   RT	  pre-­‐op	  3	   55	   Pleyomorphic	  sarc	   Left	  adductor	  compartment	  	   250	  x	  130	  x	  90	   wide	   RT	  pre-­‐op	  4	   58	   Chondroblastic	  OS	  (metastatic)	   L	  femur	  (bone)	  +	  antero-­‐medial	  thigh	  
130	  x	  550	  x	  58	   marginal	   Ct	  +	  RT	  pre-­‐op,	  CT	  post-­‐op	  
5	   75	   MFH	   L	  biceps	   225	  x	  150	  x	  85	   wide	   RT	  pre-­‐op	  6	   83	   Pleyomorphic	  sarc	   posterior	  thigh	   245	  x	  125	  x	  90	   wide	   RT	  pre-­‐op	  7	   63	   Neurofibrosarcoma	   popliteal	  fossa	   145	  x	  75	  x	  25	   wide	   Rt	  pre-­‐op	  8	   29	   MFH	  (angyomatoid)	   medial	  distal	  thigh	   230	  x	  105	  x	  55	   wide	   RT	  pre-­‐op	  9	   70	   liposarcoma	   L	  posterior	  thigh	   230	  x	  130	  x	  110	   wide	   RT	  pre-­‐op	  10	   67	   liposarcoma	   upper	  toracic,	  scapula	   125	  x	  87	  x	  30	   wide	   RT	  pre-­‐op	  11	   83	   MFH	   anterior	  arm	   115	  x	  100	  x	  30	   wide	   RT	  pre-­‐op	  12	   67	   Pleyomorphic	  sarc	   antero-­‐lateral	  thigh	   350	  x	  140	  x	  250	   wide	   RT	  pre-­‐op	  13	   66	   liposarcoma	   Anterior	  leg	   130	  x	  65	  x	  60	   wide	   RT	  pre-­‐op	  14	   	  64	   Pleyomorphic	  sarc	   medial	  prox	  thigh	   200	  x	  150	  x	  120	   wide	   RT	  pre-­‐op	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Tab.	  2	  Table	  showing	  the	  compartment	  involved,	  the	  function	  replaced	  and	  
the	  flap	  used	  	  
	  





1	   Leg,	  posterior	   Soleus	  +	  flexor	  halluci	  longus	  +	  flexor	  digitorum	  longus	   Gracilis	  +	  sural	  n	  (second	  stage)	  
2	   Hip,	  extensor	   Gluteus	  max	   TRAM	  3	   Thigh,	  adductor	   Adductors	   Gracilis	  4	   Thight,	  extensor	   Quadriceps	   Lat	  dorsi	  
5	   Arm,	  anterior	   Biceps	  +	  brachialis	   Gracilis	  (failed,	  substituted	  with	  lat	  dorsi)	  6	   Thigh,	  posterior	   Hamstrings	   Lat	  dorsi	  7	   Leg,	  posterior	   Soleus	  +	  gastrocnemius	   Parascapular	  +	  sural	  n.	  8	   Thigh,	  extensor	   VMO	  +	  rectus	  femoris	   Gracilis	  9	   Thigh,	  posterior	  and	  adductor	   Hamstrings	  +	  adductor	  magnus	   Lat	  dorsi	  10	   Scapular	  stabilizers	   Rhomboid	  +	  trapezius	   Lat	  dorsi	  (pedicled)	  11	   Arm,	  anterior	   Biceps	  +	  brachialis	   Gracilis	  12	   Thigh,	  antero-­‐lateral	   Vastus	  lateralis	  +	  rectus	  femoris	   TRAM	  13	   Leg,	  anterior	   Tibialis	  anterior	   Gracilis	  14	   Thigh,	  adductor	   Adductors	   Gracilis	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In	   the	   thigh,	   1	   patient	   had	   a	   femoral	   resection	   and	  reconstruction	   with	   megaprosthesis	   associated	   with	   anterior	  compartment	   excision;	   the	   extensor	   compartment	   was	   excised	   in	  other	   2	   patients.	   In	   2	   patients	   the	   resection	   involved	   the	   posterior	  compartment	  of	  the	  thigh,	  in	  both	  cases	  excluding	  biceps	  femoris,	  but	  in	   one	   including	   the	   adductor	   compartment.	   In	   the	   remaining	   3	  patients	  the	  excision	  involved	  the	  adductor	  compartment	  in	  2,	  and	  the	  gluteus	  maximus	  in	  the	  other.	  In	  the	  upper	  limb,	  2	  resections	  involved	  the	   anterior	   compartment	   of	   the	   arm	   and	   1	   the	   rhomboid	   and	  trapezius	  muscles.	  
The	  donor	  flap	  was	  selected	  on	  the	  base	  of	  the	  size	  of	  the	  defect	  to	  reconstruct	  and	  the	  size	  of	  the	  overlying	  skin.	  The	  overall	  resection	  was	   generally	   of	   big	   dimensions,	   measuring	   on	   average	   more	   than	  20x15x8	  cm	  (Tab	  1),	  with	  always	  a	  substantial	  skin	  resection	  involved	  as	   well	   as	   part	   of	   the	   margins.	   The	   gracilis	   myocutaneous	   flap	   was	  used	   in	   7	   patients	   (in	   6	   innervated,	   in	   one	   the	   sural	   nerve	   was	  subsequently	  implanted),	  the	  latissimus	  dorsi	  in	  3	  (in	  2	  cases	  free,	  in	  one	  pedicled),	  the	  TRAM	  in	  2	  and	  the	  free	  parascapular	  with	  the	  sural	  nerve	  in	  one	  (TAB	  2).	  
The	   vascular	   pedicles	   were	   anastomosed	   to	   nutrient	   vessels	  available	   after	   the	   tumor	   resection	   and	   the	   donor	  motor	   nerve	  was	  sutured	  to	  the	  prepared	  recipient	  nerve.	  
The	   mean	   follow	   up	   was	   16.6	   months	   (range	   8-­‐39).	   	   The	  patients	   were	   evaluated	   for:	   1)	   strength	   in	   the	   reconstructed	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There	   was	   one	   superficial	   infection	   at	   the	   donor	   site,	   treated	  with	   oral	   antibiotics	   for	   7	   days.	   In	   all	   the	   other	   cases	   the	   wound	  healed	   with	   no	   complications	   and	   without	   any	   discomfort	   for	   the	  patient.	  
In	  terms	  of	  disease	  control,	  in	  one	  case	  (the	  patient	  in	  which	  we	  could	  not	  achieve	  wide	  margins)	  there	  was	  a	  local	  recurrence	  that	  led	  to	   an	   above	   knee	   amputation.	   This	   patient	   died	   of	   the	   disease	   and,	  because	   the	   recurrence	   occurred	   at	   less	   than	   12	   months	   post-­‐operatively,	  the	  function	  of	  the	  flap	  was	  not	  recorded.	  
	  
	   85	  
Tab.	  3	  Table	  showing	  the	  complications	  related	  to	  the	  type	  of	  flap	  used,	  and	  
the	  time	  of	  occurence	  	   	   	  




1	   Gracilis	  +	  sural	  nerve	  (implanted	  in	  second	  stage)	   Wound	  break	  down	   8	  
2	   TRAM	   Nil	   -­‐	  
3	   Gracilis	   Tumor	  recurrence,	  died	  of	  disease	   90	  
4	   Latissimus	  dorsi	   Flap	  failure	  (necrosis),	  substituted	  with	  not	  innervated	  flap	   27	  
5	   Gracilis	   Flap	  failure	  (necrosis	  ),	  substituted	  with	  re-­‐innervated	  lat	  dorsi	   5	  
6	   Latissimus	  dorsi	   Lymphoedema	   7	  
7	   Parascapular	  +	  sural	  n.	   Lymphoedema	  +	  superficial	  infection	   11	  
8	   Gracilis	   Nil	   -­‐	  
9	   Latissimus	  dorsi	   Nil	   -­‐	  
10	   Latissimus	  dorsi	  (pedicled)	   Nil	   -­‐	  
11	   Gracilis	   Nil	   -­‐	  
12	   TRAM	   Superficial	  infection	  at	  donor	  site	   5	  
13	   Gracilis	   Nil	   -­‐	  
14	   Gracilis	   Tumor	  Recurrence	  (flap	  evaluated)	   420	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Of	   the	   remaining	   13	   patients	   there	   were	   a	   total	   of	   6	   post-­‐operative	   complications,	   2	   major	   and	   4	   minor	   (Tab	   3).	   The	   major	  complications	  were	  flap	  failures	  in	  both	  cases	  because	  of	  necrosis:	   in	  one	   case	   the	   original	   flap	   (gracilis)	   was	   substituted	   with	   another	  innervated	   flap	   (latissimus	  dorsi);	   in	   the	  other	  case,	   the	  original	   flap	  (gracilis)	  was	  substituted	  with	  a	  non-­‐innervated	  VRAM.	  In	  both	  these	  patients	  the	  histology	  of	  the	  removed	  flap	  confirmed	  severe	  ischaemic	  damage	  without	   signs	   of	   infection.	   Of	   these	   2	   patients,	   only	   the	   one	  with	   the	   second	   attempt	   of	   innervated	   flap	   has	   been	   evaluated	   for	  functional	  results,	  and	  the	  latissimus	  dorsi	  was	  the	  flap	  considered	  for	  evaluation.	   The	   four	   minor	   complications	   were:	   lymphoedema	   in	   3	  (one	   with	   superficial	   infection	   treated	   with	   oral	   antibiotics)	   and	  wound	   breakdown	   in	   one	   (which	   required	   debridement	   and	  superficial	   skin	   graft	   coverage).	   In	   all	   these	   patients	   with	   minor	  complications	   the	   original	   innervated	   flap	   has	   been	  maintained	   and	  therefore	  subsequently	  evaluated.	  
Therefore,	   a	   total	   of	   12	   patients	   have	   been	   evaluated	   for	  functional	   and	   emotional	   results.	   All	   of	   these	   patients	   had	   pre-­‐operative	   radiotherapy,	  with	  a	  dose	  of	  50	   to	  60	  Gy.	  The	   response	   to	  radiotherapy	   was	   good	   (>90%	   of	   necrosis	   in	   the	   final	   specimen)	   in	  75%	  of	  the	  cases,	  and	  poor	  (<90%	  of	  necrosis)	  in	  the	  remaining	  25%.	  In	  all	  but	  one	  case	  the	  response	  to	  radiotherapy	  was	  clinically	  evident,	  showing	   a	  marked	   decrease	   of	   uptake	   in	   functional	   scans	   (Thallium	  scans	   performed	   at	   30	   mins	   and	   at	   4	   hours)	   associated	   with	   a	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moderate	  increase	  in	  size	  of	  the	  lesion,	  due	  to	  the	  necrosis	  of	  the	  most	  inner	  part	  of	  the	  tumor.	  
From	  the	  functional	  point	  of	  view,	   in	  all	   the	  patients	  evaluated	  there	   was	   clinical	   evidence	   of	   re-­‐innervation	   with	   some	   degree	   of	  muscle	  function.	  All	  the	  patients,	  in	  fact,	  were	  able	  to	  move	  the	  joint	  or	  joints	   controlled	  by	   the	  muscle	   replaced.	  The	   strength	  of	   the	  muscle	  (or	  muscles)	  replaced	  was	  M5	  in	  7	  patients	  at	  a	  mean	  follow	  up	  of	  18.1	  months	  (range	  8-­‐39)	  and	  M4	  in	  5	  patients	  at	  a	  mean	  follow	  up	  of	  10.5	  months	  (range	  8-­‐14).	  	  
The	   range	   of	   motion	   (ROM)	   of	   the	   joint	   (or	   joints)	   controlled	  totally	  or	  partially	  by	  the	  innervated	  flap	  was	  complete	  in	  7	  patients,	  partial	   due	   to	   muscle	   weakness	   in	   one	   at	   an	   early	   follow	   up	   (8	  months),	   and	   partial	   for	   incomplete	   re-­‐innervation	   in	   one.	   (TAB	   3)	  Specifically,	   in	   one	   patient	   the	   muscle	   function	   replaced	   was	   the	  hamstrings,	  substituted	  by	  the	  latissimus	  dorsi,	  and,	  at	  a	  follow	  up	  of	  8	  months,	  the	  flexion	  of	  the	  knee	  was	  up	  to	  90°,	  with	  a	  strength	  of	  4/5.	  In	   the	   second	   patient,	   the	   compartment	   replaced	   was	   the	   entire	  posterior	  compartment	  of	  the	  leg,	  involving	  the	  flexor	  hallucis	  longus,	  the	   flexor	  digitorum,	   the	   soleus	  and	   the	  plantaris;	   in	   this	  patient	   the	  first	  reconstruction	  was	  with	  a	  non-­‐innervated	  gracilis	  mio-­‐cutaneous	  flap,	   which	   in	   a	   second	   time	   was	   revised	   and	   a	   vascularized	   sural	  nerve	  was	  implanted	  to	  the	  graft	  and	  anastomosed	  to	  the	  tibial	  nerve.	  The	   partial	   functional	   result	   in	   this	   particular	   case	   consists	   in	   full	  ankle	   ROM	   (soleus	   completely	   re-­‐innervated)	   but	   minimal	   plantar-­‐
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flexion	   of	   the	   toes	   with	   inability	   to	   stand	   on	   them	   at	   39	  months	   of	  follow	  up.	  From	  the	  sensation	  point	  of	  view,	  	  at	  12	  months	  of	  follow	  up	  there	  was	  no	  protective	   sensation	   and	   still	   numbness	   at	   the	   level	   of	  the	   graft;	   this	   slowly	   improved	   with,	   at	   a	   final	   follow	   up,	   complete	  painless	  sensation.	  
The	  overall	   function	  was	  excellent	   in	  all	   the	  cases.	   In	  the	  three	  patients	   in	   which	   the	   reconstruction	   involved	   the	   upper	   limb	   the	  DASH	  score	  was	  52.2%,	  61.4%	  and	  100%.	  In	  the	  lower	  limb	  the	  mean	  LEFS	  was	  78.4%	  with	  a	  range	  between	  38%	  and	  100%.	  
In	  terms	  of	  functional	  associated	  with	  emotional	  evaluation,	  the	  MSTS	  score	  resulted	   in	  a	  mean	  of	  89.1%,	  with	  a	  range	  between	  43%	  and	  100%.	  	  
There	   was	   no	   difference	   between	   upper	   limb	   and	   lower	   limb	  with	   regards	   of	   functional	   or	   emotional	   scores,	   even	   if	   it	   has	   to	   be	  considered	   that	   the	   small	   number	   of	   cohorts	   do	   not	   allow	   any	  statistical	  consideration.	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Tab.	  3	  Table	  showing	  the	  complications	  related	  to	  the	  type	  of	  flap	  used,	  and	  
the	  time	  of	  occurence	  	  
	   	  
PT	   Follow	  up	  
(months)	   Muscle	  Strength	   DASH/LEFS	   MSTS	  
1	   39	   5	   86%	   90%	  
2	   13	   5	   100%	   100%	  
3	   Died	  of	  disease	   NA	   NA	   NA	  
4	   (1)	   NA	   NA	   NA	  
5	   9	   4	   52.2%	   83%	  
6	   11	   4	   58%	   76%	  
7	   14	   4	   38%	   100%	  
8	   14	   5	   100%	   100%	  
9	   8	   4	   65%	   90%	  
10	   8	   5	   100%	   100%	  
11	   9	   4	   61.4%	   43%	  
12	   18	   5	   71%	   100%	  
13	   18	   5	   97%	   100%	  
14	   14	  	   5	   91%	   86%	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Fig.	   24	   Functional	   scores	   in	   all	   the	   patients;	   100%	   represents	   the	   best	  
outcome,	  with	   functional	   results	  compared	   to	  normal.	  DASH:	  Upper	  
Limb;	  LEFS:	  Lower	  Limb.	  
	  
	   	  
	  




Soft	   tissue	   sarcomas	   are	   aggressive	   tumors	   that	   require	  extensive	  resections	  to	  obtain	  wide	  margins.	  Free	  or	  pedicled	  muscle	  transplantations	   are	   often	   necessary	   for	   wound	   closure,	   especially	  when	  the	  resection	  involves	  a	  conspicuous	  amount	  of	  muscle	  and	  skin.	  The	   main	   goal	   of	   plastic	   reconstruction	   has	   traditionally	   been	   soft	  tissue	  coverage,	   as	   it	  has	  been	  seen	   that	   in	   the	  majority	  of	   the	   cases	  the	   remaining	   muscles	   are	   able	   to	   become	   hyperthrophic	   and	   to	  partially	   replace	   the	   function	   of	   the	   resected	   ones	   (177,	   178).	   The	  indication	   for	   a	   functional	   reconstruction	  has	  been	   limited	   therefore	  to	  the	  forearm	  and	  the	  posterior	  leg	  (178),	  but	  more	  recently	  this	  has	  been	  extended	   to	   the	   thigh,	   the	  anterior	   lower	   leg,	   the	   shoulder	   and	  the	   buttock	   (69,	   70,	   179,	   180).	   In	   this	   study	   we	   showed	   that	   these	  extended	  indications	  are	  appropriate	  and	  that,	  by	  providing	  adequate	  muscle	   function	   after	   tumor	   resection,	   the	   patient’s	   satisfaction	   and	  emotional	  status	  can	  be	  improved.	  
It	   is	   well	   known	   that	   the	   use	   of	   radiation	   therapy	   negatively	  affects	  microvascular	  surgery	  because	  it	  causes	  intimal	  damage	  of	  the	  vessels	   with	   consequent	   lower	   success	   rate	   of	   the	   anastomosis	   (62,	  181),	   therefore	   has	   been	   proposed	   that,	   when	   necessary,	   recipient	  vessels	   should	   be	   sought	   outside	   the	   field	   of	   irradiation	   to	   avoid	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vascular	  complication	  (71).	  In	  accordance	  with	  this	  statement,	  in	  fact,	  flap	  necrosis	  was	  seen	   in	  18%	  of	  our	  cases	  (2/11),	  but	   in	  both	  cases	  the	   flap	   has	   been	   replaced	   with	   another	   muscle	   transfer	   and	  subsequent	  good	  result.	  Despite	  the	  negative	  effect	  of	  radiotherapy	  on	  flap	  survival	  therefore,	  we	  showed	  that	   it	  can	  be	  possible	  to	  perform	  another	   reconstructive	   limb	   salvage	   procedure.	   Moreover,	   in	   one	   of	  the	   two	  patients	  we	  were	  able	   to	   implant	  another	  re-­‐innervated	   flap	  and	  therefore	  maintaining	  the	  chance	  of	  a	  functional	  reconstruction.	  	  
The	  complication	  rate	  after	  free	  or	  pedicled	  musculo-­‐cutaneous	  flap	  reconstruction	  is	  higher	  compared	  to	  primary	  closure	  and	  this	  is	  mainly	  due	  to	  the	  fact	  that	  patients	  receiving	  flaps	  have	  a	  significantly	  larger	   and	   higher-­‐grade	   tumors	   than	   patients	   treated	   with	   primary	  closure,	   and	   were	   more	   likely	   to	   have	   received	   preoperative	  irradiation,	  bone	  resection,	  and	  motor	  nerve	  resection	  (153).	  Each	  of	  these	   tumor	   and	   treatment	   factors	   has	   been	   associated	   with	   worse	  function	   and/or	   health	   status	   outcomes	   (4,	   154,	   157).	   In	   our	  experience,	  the	  use	  of	   innervated	  flaps	  does	  not	   increase	  the	  amount	  or	   the	   severity	   of	   post-­‐operative	   complications	   compared	   to	   non-­‐innervated	   flaps,	   while	   providing	   a	   possibly	   better	   functional	  outcome.	  In	  our	  experience,	  the	  time	  of	  the	  surgery	  and	  the	  amount	  of	  blood	  loss	  is	  not	  influenced	  by	  the	  use	  of	  an	  innervated	  flap,	  as	  shown	  by	   other	   authors	   as	   well	   (70,	   71);	   at	   the	   same	   time,	   the	   surgeon	  experience	   required	   to	   perform	   an	   innervated	   flap	   is	   the	   same	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required	  to	  perform	  a	   free	   flap,	   therefore	  no	   further	   training	  or	  high	  learning	  curve	  is	  necessary.	  
A	   limitation	   of	   this	   study,	   together	   with	   the	   small	   number	   of	  cases,	  is	  the	  lack	  of	  direct	  comparison	  between	  this	  technique	  and	  the	  standard	   not-­‐innervated	   flaps	   in	   terms	   of	   functional	   and	   emotional	  outcome.	  Our	   study	  was	  a	  preliminary	   report,	  which	  had	   the	  goal	  of	  the	   evaluation	   of	   the	   feasibility	   of	   this	   technique	   and	   the	   good	  functional	   outcome.	   In	   a	   second	   time,	   with	   a	   higher	   number	   of	  patients	  and	  with	  a	  longer	  follow	  up,	  it	  will	  be	  possible	  to	  compare	  the	  two	  cohorts	  and	  to	  definitely	  give	  an	  answer	  to	  the	  question	  whether	  or	  not	  performing	  an	  innervated	  flap	  is	  worthwhile.	  From	  these	  initial	  data,	   however,	   the	   choice	   of	   this	   innovative	   technique	   seems	  reasonable	   especially	   when	   the	   resection	   of	   the	   tumor	   involves	   a	  substantial	  amount	  of	  an	  entire	  compartment.	   In	  both	  the	  upper	  and	  the	  lower	  limb	  the	  indication	  is	  mainly	  related	  to	  the	  function:	  in	  the	  lower	   limb	  the	  most	   important	   functions	   that	  need	   to	  be	  maintained	  are	  the	  hip	  and	  the	  knee	  extension,	  and	  the	  knee	  flexion.	  In	  the	  upper	  limb,	   the	   important	   functions	   that	   allow	   the	   patient	   to	   maintain	   a	  reasonable	   quality	   of	   life	   are	   elbow	   flexion/extension	   (prono-­‐supination	   is	  usually	  not	   impaired	   if	   the	   lesion	   involves	  only	  the	  soft	  tissues),	   and	   the	  wrist	   flexion.	   In	   all	   these	   cases	  we	   believe	   that	   the	  use	   of	   re-­‐innervated	   flaps	   can	   give	   substantial	   superior	   results	  compared	   to	   standard	   reconstruction,	   associated	   with	   a	   higher	  satisfaction	  rate	  of	  the	  patients.	  






Tumors	   involving	   bone	   and	   soft	   tissues	   are	   extremely	  challenging	   situations,	   in	   which	   the	   main	   goal	   of	   the	   surgery	   is	   to	  preserve	   the	   life	   of	   the	   patient.	   With	   the	   recent	   advances	   of	   multi-­‐modal	   treatment,	   not	   only	   the	   type	   of	   surgery	   has	   moved	   from	  amputation	  to	  limb-­‐sparing	  procedures,	  but	  also	  the	  survivorship	  has	  improved	   considerably,	   moving	   from	   about	   20%	   at	   1	   year	   to	   more	  than	   70%	   at	   5	   years.	   Although	   there	   is	   a	   substantial	   variability	  between	  tumor	  types,	  the	  overall	   increase	  of	  the	  survival	  rate	  entails	  that	   there	   is	   the	   need	   to	   provide	   better	   functional	   outcome	   to	   the	  patients.	  
	  
Improvement	   in	   bone	   reconstruction	   involves	   the	   field	   of	  biological	   and	  prosthetic	   techniques;	   although	   in	  both	   areas	   there	   is	  large	  space	  for	  innovations,	  biological	  reconstructions	  have	  by	  far	  the	  higher	  chances	  to	  achieve	  substantial	  better	  outcome.	  The	  key	   factor	  that	  needs	   to	  be	  addressed	   is	   the	   re-­‐vascularization	  of	   the	  biological	  implant	  in	  order	  to	  obtain	  a	  re-­‐vitalized	  structure.	  Our	  study	  aimed	  to	  obtain	   a	   direct	   re-­‐vascularization	   of	   a	  massive	   allograft	   in	   the	   small	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experimental	   animal.	   Although	   the	   model	   had	   limitations	   and	   there	  was	  an	  important	  difficulty	  in	  the	  achievement	  of	  a	  patent	  implanted	  vessel	   in	   the	   allograft,	   we	   believe	   that	   this	   is	   a	   reasonable	   and	  promising	  approach.	  The	  future	  plan	  in	  this	  particular	  case	  will	  be	  to	  move	   onto	   the	   large	   animal,	   such	   as	   sheep,	   using	   the	   already	   well	  established	   surgical	  model,	   in	   order	   to	   prove	   the	   superiority	   of	   this	  technique	  compared	  to	  the	  standard	  ones	  used	  in	  clinic.	  
	  
Tumors	  that	  involve	  the	  soft	  tissues	  are	  approached	  with	  wide	  resection	  and	  pre	  or	  post-­‐operative	  radiotherapy.	  Even	  in	  these	  cases,	  the	  reconstruction	  that	  follows	  the	  resection	  is	  of	  extreme	  importance	  not	  only	  from	  the	  anatomic,	  but	  even	  for	  the	  functional	  point	  of	  view.	  The	  need	  for	  the	  coverage	  of	  defects	   left	  after	  the	  tumor	  excision	  led	  to	   a	   strong	   collaboration	   between	   the	   orthopaedic	   and	   the	   plastic	  team,	  with	  a	  substantial	  increase	  in	  the	  amount	  of	  flap	  reconstruction	  after	   sarcoma	  surgery.	  Even	   in	   this	   case,	   the	   increase	   in	   the	  survival	  rate	  of	   these	  patients	  pushes	   the	  surgeon	  to	  obtain	   the	  best	  possible	  functional	  outcome.	  In	  this	  study	  we	  have	  demonstrated	  that	  the	  use	  of	   the	   innovative	   technique	  of	  motor	  re-­‐innervated	  muscular	   flaps	   is	  effective	   when	   the	   resection	   involved	   important	   functional	  compartments	   of	   the	   upper	   or	   lower	   limb.	   Although	   there	   was	   no	  direct	   comparison	   between	   this	   type	   of	   reconstruction	   and	   the	  standard	  non-­‐innervated	  reconstruction,	  e	  underlined	  how	  the	  patient	  satisfaction	  and	  the	  overall	  functional	  scores	  were	  noticeably	  high.	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There	  is	  the	  need	  for	  further	  studies	  and,	  at	  the	  same	  time,	  for	  a	  deeper	  understanding	  of	  the	  biology	  processes	  that	  drive	  to	  bone	  and	  muscle	   re-­‐generation	   and	   re-­‐vitalization,	   with	   consequent	   re-­‐establishment	   of	   function,	   but	   the	   results	   obtained	   in	   these	  preliminary	  studies	  are	  certainly	  promising	  and	  encouraging.	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